SigmaTron International (SGMA) 10-K 21 Jul 23 2023 FY Annual report Financial data

Document And Entity Information

Document And Entity Information - USD ($)	12 Months Ended
	Apr. 30, 2023	Jul. 14, 2023	Oct. 31, 2022
Document And Entity Information [Abstract]
Document Type	10-K
Document Annual Report	true
Document Fiscal Period Focus	FY
Current Fiscal Year End Date	--04-30
Document Fiscal Year Focus	2023
Document Period End Date	Apr. 30, 2023
Document Transition Report	false
Entity File Number	0-23248
Entity Registrant Name	SIGMATRON INTERNATIONAL, INC.
Entity Incorporation State Country Code	DE
Entity Tax Identification Number	36-3918470
Entity Address Address Line 1	2201 Landmeier Rd.
Entity Address City Or Town	Elk Grove Village
Entity Address State Or Province	IL
Entity Address Postal Zip Code	60007
City Area Code	847
Local Phone Number	956-8000
Title of 12b Security	Common Stock $0.01 par value per share
Trading Symbol	SGMA
Security Exchange Name	NASDAQ
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Public Float			$ 23,548,787
Entity Common Stock, Shares Outstanding		6,091,288
Documents Incorporated by Reference	Certain sections or portions of the definitive proxy statement of SigmaTron International, Inc., for use in connection with its 2023 annual meeting of stockholders, which the Company intends to file within 120 days of the fiscal year ended April 30, 2023, are incorporated by reference into Part III of this Form 10-K.
Amendment Flag	false
Entity Central Index Key	0000915358
Auditor Name	BDO USA, P.A
Auditor Location	Chicago, Illinois
Auditor Firm ID	243
ICFR Auditor Attestation Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Current assets:
Cash and cash equivalents	$ 819,129	$ 2,498,589
Accounts receivable, less allowance for doubtful accounts of $100,000 at April 30, 2023 and April 30, 2022	46,284,818	41,071,740
Inventories, net	165,555,199	164,664,965
Prepaid expenses and other assets	1,678,263	2,151,827
Refundable and prepaid income taxes	779,705	1,238,973
Other receivables	5,349,328	6,318,164
Current assets of discontinued operations		999,881
Total current assets	220,466,442	218,944,139
Property, machinery and equipment, net	35,788,357	35,778,106
Intangible assets, net	1,311,030	1,650,163
Deferred income taxes	2,640,902	856,863
Right-of-use assets	7,225,423	10,946,764
Other assets	1,195,045	1,174,284
Assets of discontinued operations		24,280,958
Total other long-term assets	12,372,400	38,909,032
Total assets	268,627,199	293,631,277
Current liabilities:
Trade accounts payable	75,159,716	95,953,429
Accrued expenses	2,933,430	2,753,102
Accrued wages	7,917,266	9,077,849
Income taxes payable	1,041,998	802,556
Deferred revenue	8,063,197	11,394,820
Current portion of long-term debt	52,761,520	6,991,567
Current portion of finance lease obligations	1,523,259	1,410,675
Current portion of operating lease obligations	2,908,213	3,508,864
Current liabilities of discontinued operations		608,333
Total current liabilities	152,308,599	132,501,195
Long-term debt, less current portion	40,539,180	60,099,402
Finance lease obligations, less current portion	2,596,178	2,805,135
Operating lease obligations, less current portion	4,723,867	7,903,898
Income taxes payable	267,998	357,331
Deferred income taxes		363,732
Other long-term liabilities	100,350	1,051,587
Long-term liabilities of discontinued operations		215,000
Total long-term liabilities	48,227,573	72,796,085
Total liabilities	200,536,172	205,297,280
Commitments and contingencies
Stockholders' equity:
Preferred stock, $0.01 par value; 500,000 shares authorized, none issued or outstanding
Common stock, $0.01 par value; 12,000,000 shares authorized, 6,091,288 and 6,026,788 shares issued and outstanding at April 30, 2023 and April 30, 2022, respectively	60,634	60,379
Capital in excess of par value	41,986,570	41,654,410
Retained earnings	26,043,823	46,619,208
Total stockholders' equity	68,091,027	88,333,997
Total liabilities and stockholders' equity	$ 268,627,199	$ 293,631,277

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Consolidated Balance Sheets [Abstract]
Accounts receivable, allowance for doubtful accounts	$ 100,000	$ 100,000
Preferred stock, par value	$ 0.01	$ 0.01
Preferred stock, shares authorized	500,000	500,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Common stock, par value	$ 0.01	$ 0.01
Common stock, shares authorized	12,000,000	12,000,000
Common stock, shares issued	6,091,288	6,026,788
Common stock, shares outstanding	6,091,288	6,026,788

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Consolidated Statements Of Income [Abstract]
Net sales	$ 414,435,845	$ 378,316,495
Cost of products sold	362,982,248	333,925,226
Gross profit	51,453,597	44,391,269
Selling and administrative expenses	26,495,951	25,981,794
Operating income	24,957,646	18,409,475
Gain on extinguishment of long-term debt		6,282,973
Other income	632,223	153,614
Interest expense, net	(8,403,904)	(1,500,140)
Income before income taxes	17,185,965	23,345,922
Income tax expense	(2,991,541)	(4,980,003)
Net income from continuing operations	14,194,424	18,365,919
Loss before tax from discontinued operations	(36,629,902)	(9,180,064)
Income tax benefit from discontinued operations	1,860,093	678,313
Net loss from discontinued operations	(34,769,809)	(8,501,751)
Net (loss) income	$ (20,575,385)	$ 9,864,168
Basic (loss) earnings per common share:
Income from continuing operations	$ 2.34	$ 3.81
Loss from discontinued operations	(5.73)	(1.77)
Basic (loss) earnings per common share:	(3.39)	2.04
Earnings Per Share, Diluted [Abstract]
Income from continuing operations	2.34	3.58
Loss from discontinued operations	(5.73)	(1.66)
Diluted (loss) earnings per common share:	$ (3.39)	$ 1.92
Weighted average shares of common stock outstanding - Basic	6,069,680	4,825,360
Weighted average shares of common stock outstanding - Diluted	6,069,680	5,129,234

Consolidated Statements Of Chan

Consolidated Statements Of Changes In Stockholders' Equity - USD ($)	Preferred Stock [Member]	Common Stock [Member]	Capital In Excess Of Par Value [Member]	Retained Earnings [Member]	Total
Balance at Apr. 30, 2021		$ 42,560	$ 23,751,461	$ 36,755,040	$ 60,549,061
Recognition of stock-based compensation			622,244		622,244
Exercise of stock options		1,857	915,735		917,592
Restricted stock awards		176	127,340		127,516
Issuance of stock - for settlement of lease agreement		320	276,800		277,120
Issuance of stock for acquisition		24,439	25,220,738		25,245,177
Purchase of treasury stock related to acquisition		(8,973)	(9,259,908)		(9,268,881)
Net loss from discontinued operations				(8,501,751)	(8,501,751)
Net income from continuing operations				18,365,919	18,365,919
Net (loss) income					9,864,168
Balance at Apr. 30, 2022		60,379	41,654,410	46,619,208	88,333,997
Recognition of stock-based compensation			184,343		184,343
Restricted stock awards		255	147,817		148,072
Net loss from discontinued operations				(34,769,809)	(34,769,809)
Net income from continuing operations				14,194,424	14,194,424
Net (loss) income					(20,575,385)
Balance at Apr. 30, 2023		$ 60,634	$ 41,986,570	$ 26,043,823	$ 68,091,027

Consolidated Statements Of Cash

Consolidated Statements Of Cash Flows - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Cash flows from operating activities
Net income from continuing operations	$ 14,194,424	$ 18,365,919
Net loss from discontinued operations	(34,769,809)	(8,501,751)
Adjustments to reconcile net income to net cash used in operating activities from continuing operations
Depreciation and amortization of property, machinery and equipment	5,817,659	5,720,157
Stock-based compensation	184,343	622,244
Restricted stock expense	148,072	127,516
Impairment of notes receivable and investment		6,300,235
Provision for inventory obsolescence	488,000	1,711,599
Deferred income tax expense (benefit)	(2,362,771)	1,154,012
Gain on extinguishment of long-term debt		(6,282,973)
Amortization of intangible assets	339,133	346,586
Amortization of financing fees	358,515	81,130
Gain from involuntary conversion on non-monetary assets due to fire	(469,849)
Loss from disposal or sale of machinery and equipment	15,419	24,970
Changes in operating assets and liabilities, net of acquisition
Accounts receivable	(5,328,740)	(12,288,539)
Inventories	(2,819,297)	(68,297,962)
Prepaid expenses and other assets	5,954,202	(1,784,499)
Refundable and prepaid income taxes	468,790	(850,207)
Income taxes payable	150,109	(576,592)
Trade accounts payable	(20,702,026)	33,299,432
Deferred revenue	(3,179,709)	10,487,828
Operating lease liabilities	(3,780,682)	(2,552,673)
Accrued expenses and wages	(2,732,396)	10,094
Net cash used in operating activities from continuing operations	(13,256,804)	(14,381,723)
Cash flows from investing activities from continuing operations
Purchases of machinery and equipment	(4,334,169)	(4,740,100)
Proceeds from the sale of business	1
Advances on notes receivable	(900,000)	(5,512,000)
Proceeds from insurance settlement	54,921
Net cash used in investing activities from continuing operations	(5,179,247)	(10,252,100)
Cash flows from financing activities from continuing operations
Proceeds from the exercise of common stock options		917,592
Proceeds under equipment note	416,728	1,412,005
Payments under finance lease and sale leaseback agreements	(1,695,829)	(1,855,822)
Payments under equipment note	(1,094,905)	(1,133,352)
Payments under building notes payable	(6,042,197)	(478,423)
Borrowings under term loan agreement	40,000,000
Payments under term loan agreement	(750,000)
Borrowings under revolving line of credit	454,991,301	450,182,580
Payments under revolving line of credit	(460,103,679)	(418,758,090)
Payments of debt financing costs	(1,566,032)	(514,672)
Payments of debt		(295,747)
Net cash provided by financing activities from continuing operations	24,155,387	29,476,071
Cash flows from discontinued operations:
Net cash used in operating activities	(7,264,377)	(5,843,456)
Net cash used in investing activities	(134,419)	548,842
Net cash used in discontinued operations	(7,398,796)	(5,294,614)
Change in cash and cash equivalents	(1,679,460)	(452,366)
Cash and cash equivalents at beginning of year	2,498,589	2,950,955
Cash and cash equivalents at end of year	819,129	2,498,589
Supplementary disclosures of cash flow information
Cash paid for interest	7,765,467	1,470,789
Cash paid for income taxes	2,650,641	4,575,349
Purchase of machinery and equipment financed under finance leases	1,599,456	3,435,498
Financing of insurance policy	$ 391,437	201,226
Issuance of stock for settlement of lease agreement		$ 277,120

Description Of The Business

Description Of The Business	12 Months Ended
	Apr. 30, 2023
Description Of The Business [Abstract]
Description of the Business	NOTE A - DESCRIP TION OF THE BUSINESS SigmaTron International, Inc., its subsidiaries, foreign enterprises and international procurement office (collectively, the “Company”) operated as an independent provider of electronic manufacturing services (“EMS”) and a provider of products to the Pet Tech market. The Pet Tech Segment was sold, effective as of April 1, 2023. The EMS segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. The Pet Tech reportable segment offered electronic products such as the Freedom Smart Dog Collar™, a wireless geo-mapped fence and wellness system, along with apparel and accessories. In connection with the production of assembled products, the EMS segment also provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into a Stock Purchase Agreement (“SPA”) by and among the Company, Wagz, Vynetic LLC, a Delaware limited liability company (“Buyer”), and Terry B. Anderton, co-founder of Wagz and principal of Buyer (“Anderton”), pursuant to which the Company sold to Buyer 81 % of the issued and outstanding shares of common stock of Wagz (the “Shares”) for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a $ 900,000 working capital term loan (the “Wagz Loan”) to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated effective as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19 % ownership of the shares and Buyer holds a majority 81 % of the shares. As of April 30, 2023, the Company provided manufacturing services through an international network of facilities located in the United States, Mexico, China, Vietnam and Taiwan. Approximately 37 % of the total assets of the Company are located in foreign jurisdictions outside the United States as of April 30, 2023; 25 % and 10 % of the total assets were located in Mexico and China, respectively, and 2 % in other foreign locations. As of April 30, 2022, approximately 35 % of the total assets were located in foreign jurisdictions; 20 % and 12 % were located in China and Mexico, respectively, and 3 % in other foreign locations.

Summary Of Significant Accounti

Summary Of Significant Accounting Policies	12 Months Ended
	Apr. 30, 2023
Significant Accounting Policies [Abstract]
Summary Of Significant Accounting Policies	NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Consolidation Policy The consolidated financial statements include the accounts and transactions of SigmaTron International, Inc. (“SigmaTron”), its wholly-owned subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., SigmaTron International Trading Co., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co. Ltd., and Wujiang SigmaTron Electronic Technology Co., Ltd. (collectively, “SigmaTron China”), its international procurement office, SigmaTron International Inc. Taiwan Branch, and Wagz, Inc. (majority of business sold, effective as of April 1, 2023). The functional currency of the Mexican, Vietnamese and Chinese subsidiaries and procurement branch is the U.S. Dollar. Intercompany transactions are eliminated in the consolidated financial statements. The impact of currency fluctuations for the fiscal year ended April 30, 2023, resulted in net foreign currency transaction losses of $ 892,642 compared to net foreign currency losses of $ 412,218 in the prior year. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Discontinued Operations On April 1, 2023, SigmaTron completed the sale of its Wagz, Inc. business. In accordance with the authoritative guidance for discontinued operations (Accounting Standards Codification (ASC) 205-20), the Company determined that the Wagz, Inc. business met discontinued operations accounting criteria at the end of the fourth quarter of fiscal year 2023. The results of the Wagz, Inc. business and the related cash flows have been reported as discontinued operations in the Consolidated Statements of Operations and Consolidated Statements of Cash Flows, respectively, through the date of sale. These changes have been applied to all periods presented. See Note P — Discontinued Operations, for additional information. Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for doubtful accounts, excess and obsolete reserves for inventory, deferred income, deferred taxes, valuation allowance for deferred taxes and valuation of goodwill and long-lived assets. Actual results could materially differ from these estimates. Cash and Cash Equivalents Cash and cash equivalents include cash and all highly liquid short-term investments with original maturities within three months of the purchase date. Accounts Receivable The majority of the Company’s accounts receivable are due from companies in the industrial electronics, consumer electronics and medical/life sciences industries. Credit is extended based on evaluation of a customer’s financial condition, and, generally, collateral is not required. Accounts receivable are due in accordance with agreed upon terms, and are stated at amounts due from customers net of an allowance for doubtful accounts. Accounts outstanding longer than the contractual payments terms are considered past due. The Company writes off accounts receivable when they are determined to be uncollectible. Financing Receivables The Company has arrangements with various financial institutions to sell certain eligible accounts receivable balances from specific customers without recourse. The accounts receivable balances sold are at the election of the Company. The Company incurred fees for such sales, which are reflected as selling and administrative expenses on the Company’s Consolidated Statements of Operations and were not material for the fiscal years ended April 30, 2023 and 2022. The accounts receivable balances are derecognized at the time of sale, as the Company does not have continuing involvement after the point of sale. During the years ended April 30, 2023 and April 30, 2022, the Company sold without recourse trade receivables of approximately $ 94,000,000 and $ 121,000,000 , respectively. Cash proceeds from these agreements are reflected as operating activities included in the change in accounts receivable in the Company's Consolidated Statements of Cash Flows. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Allowance for Doubtful Accounts The Company’s allowance for doubtful accounts relates to receivables not expected to be collected from its customers. This allowance is based on management’s assessment of specific customer balances, considering the age of receivables and financial stability of the customer and a five-year average of prior uncollectible amounts. If there is an adverse change in the financial condition of the Company’s customers, or if actual defaults are higher than provided for, an addition to the allowance may be necessary. Inventories Inventories are valued at cost. Cost is determined by an average cost method and the Company allocates labor and overhead to work-in-process and finished goods. In the event of an inventory write-down, the Company records expense to state the inventory at lower of cost or net realizable value. The Company establishes inventory reserves for shrinkage and excess and obsolete inventory. The Company records provisions for inventory shrinkage based on historical experience to account for unmeasured usage or loss. Of the Company’s raw materials inventory, a substantial portion has been purchased to fulfill committed future orders or for which the Company is contractually entitled to recover its costs from its customers. For the remaining raw materials inventory, a provision for excess and obsolete inventories is recorded for the difference between the cost of inventory and its estimated realizable value based on assumptions about future product demand and market conditions. Upon a subsequent sale or disposal of the impaired inventory, the corresponding reserve is relieved to ensure the cost basis of the inventory reflects any reductions. Actual results differing from these estimates could significantly affect the Company’s inventories and cost of products sold as the inventory is sold or otherwise relieved. Property, Machinery and Equipment Property, machinery and equipment are valued at cost. The Company provides for depreciation and amortization using the straight-line method over the estimated useful life of the assets: Buildings 20 years Machinery and equipment 5 - 12 years Office equipment and software 3 - 5 years Tools and dies 12 months Leasehold improvements lesser of lease term or useful life Expenses for repairs and maintenance are charged to selling and administrative expenses as incurred. Deferred Financing Costs Deferred financing costs consist of costs incurred to obtain the Company’s long-term debt and are amortized using the straight line method, which approximates the effective interest method, over the term of the related debt. Deferred financing fees of $ 1,608,558 and $ 401,040 net of accumulated amortization of $ 457,992 and $ 99,477 , respectively, as of April 30, 2023 and 2022, respectively, are deducted from long term debt on the Company’s Consolidated Balance Sheet. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Risks and Uncertainties Since 2020, the global COVID-19 pandemic has created significant business disruption and economic uncertainty which adversely impacted our manufacturing operations, supply chain, and distribution channels. While the immediate impacts of the COVID-19 pandemic have been assessed, the long-term effects of the disruption, including supply chain disruption, and resulting impact on the global economy and capital markets remain unpredictable, and depend on future developments such as the potential resurgence of the crisis, variant strains of the virus, vaccine availability and effectiveness, and future government actions in response to the crisis. This unpredictability could limit our ability to respond to future developments quickly. Income Taxes The Company’s income tax expense, deferred tax assets and liabilities and reserves for unrecognized tax benefits reflect management’s best assessment of estimated future taxes to be paid. The Company is subject to income taxes in both the U.S. and several foreign jurisdictions. Significant judgments and estimates by management are required in determining the consolidated income tax expense assessment. Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. In evaluating the Company’s ability to recover its deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, the Company begins with historical results and changes in accounting policies, and incorporates assumptions including the amount of future state, federal and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment and estimates by management about the forecasts of future taxable income and are consistent with the plans and estimates the Company uses to manage the underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income and/or loss. Valuation allowances are established when necessary to reduce deferred income tax assets to an amount more likely than not to be realized. A tax benefit from an uncertain tax position may only be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across its global operations. Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Except as noted below, management is not aware of any such changes that would have a material effect on the Company’s results of operations, cash flows or financial position. The Company adjusts its tax liabilities when its judgment changes as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from its current estimate of the tax liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which they are determined. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Earnings per Share Basic earnings per share are computed by dividing net income (loss) (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. The computation of diluted earnings per share is similar to the computation of basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive common stock equivalents such as stock options and restricted stock, had been exercised or vested. There were 105,286 anti-dilutive common stock equivalents and no anti-dilutive common stock equivalents at April 30, 2023 and April 30, 2022, respectively, which have been excluded from the calculation of diluted earnings per share. Fiscal Years Ended April 30, 2023 2022 Net income from continuing operations $ 14,194,424 $ 18,365,919 Net loss from discontinued operations ( 34,769,809 ) ( 8,501,751 ) Total net (loss) income ( 20,575,385 ) 9,864,168 Weighted-average shares Basic 6,069,680 4,825,360 Effect of dilutive stock options - 303,874 Diluted 6,069,680 5,129,234 Basic (loss) earnings per common share Basic earnings per share from continuing operations 2.34 3.81 Basic loss per share from discontinued operations ( 5.73 ) ( 1.77 ) Basic total (loss) earnings per share $ ( 3.39 ) $ 2.04 Diluted (loss) earnings per common share Diluted earnings per share from continuing operations 2.34 3.58 Diluted loss per share from discontinued operations ( 5.73 ) ( 1.66 ) Diluted total (loss) earnings per share $ ( 3.39 ) $ 1.92 Revenue Recognition The Company recognizes revenue when control of the promised goods or services are transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s primary performance obligation to its customers is the production of finished goods electronic assembly products pursuant to purchase orders. The Company has concluded that control of the products it sells and transfers to its customers and an enforceable right to receive payment is customarily established at the point in time when the finished goods are shipped to its customers, or in some cases delivered pursuant to the specified shipping terms of each customer arrangement. With respect to consignment arrangements, control transfers and revenue is recognized at the point in time when the goods are shipped to the customer from the consignment location or when delivered to the customer (pursuant to agreed upon shipping terms). In those limited instances where finished goods delivered to the customer location are stored in a segregated area which are not controlled by the customer (title transfer) until they are pulled from the segregated area and consumed by the Company’s customer, revenue is recognized upon consumption. For tooling services, the Company’s performance obligation is satisfied at the point in time when the customer takes legal possession of dies or molds, which accounted for less than 1% of the Company’s NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Revenue Recognition - Continued revenue. For engineering, design, and testing services, the Company’s performance obligations are satisfied over time as the respective services are rendered as its customers simultaneously derive value from the Company’s performance. From the time that a customer purchase order is received and contract is established, the Company’s performance obligations are typically fulfilled within a few weeks after receipt of all material. The Company does not have any performance obligations that require more than 12 months to fulfill. Each customer purchase order sets forth the transaction price for the products and services purchased under that arrangement. The Company evaluates the credit worthiness of its customers and exercises judgment to recognize revenue based upon the amount the Company expects to be paid for each sales transaction it enters into with its customers. Some customer arrangements include variable consideration, such as volume rebates, some of which depend upon the Company’s customers meeting specified performance criteria, such as a purchasing level over a period of time. The Company exercises judgment to estimate the most likely amount of variable consideration at each reporting date. The Company’s typical payment terms are 30 days and its sales arrangements do not contain any significant financing component for its customers. The Company’s customer arrangements do not generate contract assets that are material to the consolidated financial statements. Contract liabilities consist of payments received in advance of the transfer of control to the customer. As products are delivered and control transfers, the Company recognizes the deferred revenue in net sales in the Consolidated Statements of Operations. The following table summarizes the deferred revenue associated with payments received in advance of the transfer of control to the customer reported as deferred revenue in the Consolidated Balance Sheets and amounts recognized through net sales for each period presented. Fiscal Years Ended April 30, 2023 2022 Contract Liability (deferred revenue) $ 8,063,197 $ 11,394,820 Revenue recognized in the period from amounts included in the contact liability at the beginning of the period $ 11,394,820 $ 423,971 The Company generally provides a warranty for workmanship, unless the assembly was designed by the Company, in which case it warrants assembly/design. The Company assembles and tests assemblies based on customers’ specifications prior to shipment. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s standard or extended warranties. The Company does not provide its customers the option to purchase additional warranties and, therefore, the Company’s warranties are not considered a separate service or performance obligation. The Company utilizes the practical expedient to treat shipping and handling activities after the customer obtains control as fulfillment activities. The Company records shipping and handling costs as selling and administrative expenses and costs are accrued when revenue is recognized. The Company pays sales commissions to its sales representatives which may be considered as incremental costs to obtain a contract. However, since the recoverability period is less than one year, the Company utilizes the practical expedient provided by the revenue recognition accounting standard that allows an entity to expense the costs of obtaining a contract as incurred. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Revenue Recognition - Continued During fiscal year 2023, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods and no amounts were allocated to performance obligations that remain unsatisfied or partially unsatisfied at April 30, 2023. The Company is electing not to disclose the value of the remaining unsatisfied performance obligation with a duration of one year or less as permitted by the practical expedient in ASU 2014-09, “ Revenue from Contracts with Customers.” The Company had no material remaining unsatisfied performance obligations as of April 30, 2023, with an expected duration of greater than one year. The majority of sales are made to U.S. based customers. The following table presents the Company’s revenue disaggregated by the principal end-user markets it serves: Year Ended April 30, Year Ended April 30, Net sales by end-market 2023 2022 Industrial Electronics $ 278,844,264 $ 209,405,083 Consumer Electronics 109,043,652 145,972,308 Medical / Life Sciences 26,547,929 22,939,104 Total Net Sales $ 414,435,845 $ 378,316,495 Shipping and Handling Costs The Company records shipping and handling costs for goods shipped to customers as selling and administrative expenses. Customers are typically invoiced for shipping costs and such amounts are included in net sales. Shipping and handling costs were not material to the financial statements for fiscal years 2023 or 2022. Fair Value Measurements Fair value measurements are determined based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs. The Company utilizes a fair value hierarchy based upon the observability of inputs used in valuation techniques as follows: Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions. Fair Value of Financial Instruments The Company’s financial instruments include cash and cash equivalents, accounts receivable, note receivable, other receivables, accounts payable and accrued expenses which approximate fair value at April 30, 2023 and April 30, 2022, due to their short-term nature and are considered Level 1. The carrying amounts of the Company’s debt obligations approximate fair value based on future payments discounted at current interest rates for similar obligations or interest rates which fluctuate with the market and are considered Level 2. Intangible Assets Intangible assets are comprised of finite life intangible assets including customer relationships, trade names and patents. Finite life intangible assets are amortized on a straight line basis over their estimated useful lives of 20 years for trade names, 18 years for patents, and customer relationships which are amortized on an accelerated basis over their estimated useful life of 15 years. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Impairment of Long-Lived Assets The Company reviews long-lived assets, including amortizable intangible assets, for impairment in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360: Property, Plant and Equipment . Property, machinery and equipment and finite life intangible assets are reviewed whenever events or changes in circumstances occur that indicate possible impairment. If events or changes in circumstances occur that indicate possible impairment, the Company first performs an impairment review based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of its assets and liabilities. This analysis requires management judgment with respect to changes in technology, the continued success of product lines, and future volume, revenue and expense growth rates. If the carrying value exceeds the undiscounted cash flows, the Company records an impairment, if any, for the difference between the estimated fair value of the asset group and its carrying value. The Company further conducts annual reviews of its long-lived asset groups for possible impairment. During the third quarter of fiscal 2023, the Company revised the financial outlook for the Pet Tech segment, resulting in lower projected sales and net income for future periods. The Company assessed the overall market acceptance of the current Wagz product offerings after the holiday season and determined that this constituted a triggering event for the Company’s long-lived asset groups, primarily consisting of patents, trade names and certain fixed assets. The Company reviewed the undiscounted future cash flows for the identified long-lived asset group, and the results of the analysis indicated the carrying amount for the long-lived group was not expected to be recovered. The fair value of the identified intangible assets was estimated using the relief from royalty method, which is a risk-adjusted discounted cash flow approach. The relief from royalty method values an intangible asset by estimating the royalties saved through ownership of the asset. The relief from royalty method requires identifying the future revenue that would be generated by the intangible asset, multiplying it by a royalty rate deemed to be avoided through ownership of the asset and discounting the projected royalty savings amounts back to the acquisition date using the internal rate of return. The Company determined the fair value of the long-lived asset group was lower than its carrying value and recorded an intangible asset impairment charge of $ 9,527,773 during the third quarter of fiscal 2023. This non-cash charge was recorded to impairment of goodwill and intangible assets on the unaudited condensed consolidated statements of operations as of January 31, 2023. As of April 30, 2023 this non-cash charge has been reported under discontinued operations. See Note H – Intangible Assets and Note P – Discontinued Operations, for more information. The Company’s analysis for 2023 did not indicate that any of its other long-lived assets were impaired. The Company has yet to experience significant cancellations of orders; however, the potential impact of future disruptions, may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders. Goodwill Goodwill represents the excess cost over fair value of the net assets of acquired businesses. The Company does not amortize goodwill and intangible assets that have indefinite lives. The Company performs an impairment assessment of goodwill and intangible assets with indefinite lives annually, or more frequently if triggering events occur, based on the estimated fair value of the related reporting unit or intangible asset. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. When performing its annual impairment assessment as of April 30, the Company evaluates the goodwill assigned to each of its reporting units for potential impairment by comparing the estimated fair value of the relevant reporting unit to the carrying value. The Company uses various Level 2 and Level 3 valuation techniques to determine the fair value of its reporting units, including discounting estimated future cash flows based on a cash flow forecast prepared by the relevant reporting unit and market multiples of relevant public companies. If the fair value of a reporting unit is less than its carrying value, a goodwill impairment loss is recorded for the difference. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Goodwill - Continued The Company observed during the third quarter of fiscal 2023, the overall lack of market acceptance of the current Wagz product offerings during the holiday season and determined this constituted a triggering event. Accordingly, the Company performed a quantitative goodwill impairment test and estimated the fair value of the Pet Tech segment based on a combination of an income approach (estimates of future discounted cash flows), a market approach (market multiples for similar companies) and a cost approach. Significant unobservable inputs and assumptions inherent in the valuation methodologies, which represented Level 3 inputs, under the fair value hierarchy, were employed and included, but were not limited to, prospective financial information, terminal value assumptions, discount rates, and multiples from comparable publicly traded companies in the Pet Tech industry. The cost approach is based on upon the concept of replacement cost as an indicator of value. Stated another way, this approach is premised on the assumption that a prudent investor would pay no more for an asset than the amount for which the asset could be replaced. The cost approach establishes value based on the cost reproducing or replacing the property, less depreciation from physical deterioration and functional obsolescence, if present and measurable. During the third quarter of fiscal 2023, the Company determined its goodwill was fully impaired as the fair value was lower than the carrying value and recorded an impairment charge of $ 13,320,534 . This non-cash charge was recorded to impairment of goodwill and intangible assets on the unaudited condensed consolidated statements of operations. As of April 30, 2023 this non-cash charge has been reported under discontinued operations. See Note P – Discontinued Operations, for more information. Investment in Wagz On December 31, 2021, the Company acquired 100 % of the stock of Wagz under the terms of the Agreement and Plan of Merger dated July 19, 2021, as amended by the First Amendment to Agreement and Plan of Merger dated December 7, 2021 (the “Merger Agreement”) . Wagz has developed and brought to market a high tech pet collar and has multiple other products in development. Wagz is an internet of things (“IoT”) company which both owns intellectual property and secures recurring revenue through subscriptions for its services. Prior to the acquisition, the Company had an investment in Wagz of $ 600,000 , Convertible Secured Promissory Notes issued by Wagz of $ 12,000,000 and Secured Promissory Notes issued by Wagz of $ 1,380,705 . Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5 % ownership in Wagz. The Company's 25.5 % equity interest in Wagz common stock was remeasured to fair value of $ 6,299,765 , resulting in a non-cash impairment charge of $ 6,300,235 within the Statements of Operations during fiscal year 2022. Pursuant to the Merger Agreement, 2,443,870 shares of common stock of the Company were issued in the merger for a value of 25,245,177 , of which 1,546,592 shares are allocated to Wagz shareholders (excluding the Company) for a total value of $ 15,976,295 , and 897,278 shares are allocated to the Company and treated as treasury stock for a total value of $ 9,268,881 , recorded in the Statements of Changes in Stockholders’ Equity for the fiscal year 2022. The treasury shares were retired as of April 30, 2022. On April 28, 2023, effective as of April 1, 2023, the Company sold a majority of its interest in Wagz, which operated the Pet Tech business. Please refer to Note F – Acquisition, for more information. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Stock Incentive Plans Under the Company’s stock option plans, options to acquire shares of SigmaTron’s common stock have been made available for grant to certain employees. Each option granted has an exercise price of not less than 100 % of the market value of the common stock on the date of grant. The contractual life of each option is generally 10 years. The vesting of the grants varies according to the individual options granted. The Company measures the cost of employee services received in exchange for an equity award based on the grant date fair value and records that cost over the respective vesting period of the award. The Company has a restricted stock plan under which non-employee directors may acquire shares of SigmaTron’s common stock. The restricted stock plan has been approved by the Company’s stockholders. The restricted stock plan is interpreted and administered by the Compensation Committee of SigmaTron’s Board of Directors. All awarded stock under the plan vests in six months from the date of grant. Awarded stock under this plan is granted at the closing price of SigmaTron’s common stock on the date of grant. New Accounting Standards In June 2016, the FASB issued ASU No. 2016-13, “ Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments .” ASU 2016-13, as amended by ASU 2019-04 and ASU 2019-05, that introduces a new forward-looking approach, based on expected losses, to estimate credit losses on certain types of financial instruments, including trade receivables. The estimate of expected credit losses will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. This ASU also expands the disclosure requirements to enable users of financial statements to understand the entity’s assumptions, models and methods for estimating expected credit losses. For smaller reporting companies, ASU 2016- 13 is effective for annual and interim reporting periods beginning after December 15, 2022, and the guidance is to be applied using the modified-retrospective approach. Earlier adoption is permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements but is not expected to have a material impact on the consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, “ Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ”, which provides optional expedients and exceptions for a period of time to ease the potential burden in accounting for the transition from reference rates that are expected to

Allowance For Doubtful Accounts

Allowance For Doubtful Accounts	12 Months Ended
	Apr. 30, 2023
Allowance For Doubtful Accounts [Abstract]
Allowance For Doubtful Accounts	NOTE C - ALLOWANCE FOR DOUBTFUL ACCOUNTS Changes in the Company’s allowance for doubtful accounts are as follows: 2023 2022 Beginning Balance $ 100,000 $ 100,000 Bad debt expense - - Bad debt recovery - - Write-offs - - $ 100,000 $ 100,000

Inventories

Inventories	12 Months Ended
	Apr. 30, 2023
Inventories [Abstract]
Inventories	NOTE D - INVENTORIES Inventories consist of the following at April 30: 2023 2022 Finished products $ 22,093,018 $ 21,875,390 Work-in-process 5,415,917 5,907,766 Raw materials 142,612,325 140,118,156 170,121,260 167,901,312 Less obsolescence reserve 4,566,061 3,236,347 $ 165,555,199 $ 164,664,965 Changes in the Company’s inventory obsolescence reserve are as follows: 2023 2022 Beginning balance $ 3,236,347 $ 2,414,310 Provision for obsolescence 488,000 1,711,599 Provision for Wagz inventory 1,441,063 - Write-offs ( 599,349 ) ( 889,562 ) $ 4,566,061 $ 3,236,347

Property, Machinery And Equipme

Property, Machinery And Equipment, Net	12 Months Ended
	Apr. 30, 2023
Property, Machinery And Equipment, Net [Abstract]
Property, Machinery And Equipment, Net	NOTE E - PROPERTY, MACHINERY AND EQUIPMENT, NET Property, machinery and equipment consist of the following at April 30: 2023 2022 Land and buildings $ 18,826,246 $ 18,653,248 Machinery and equipment 85,895,593 81,551,714 Office equipment and software 14,675,432 13,738,965 Leasehold improvements 3,137,540 3,016,857 Equipment under finance leases 6,300,225 6,642,719 128,835,036 123,603,503 Less accumulated depreciation and amortization, including accumulated amortization of assets under finance leases of $ 1,006,128 and $ 1,081,476 at April 30, 2023 and 2022, respectively 93,046,679 87,825,397 Property, machinery and equipment, net $ 35,788,357 $ 35,778,106 Depreciation and amortization expense of property, machinery and equipment was $ 5,817,659 and $ 5,720,157 for the fiscal years ended April 30, 2023 and April 30, 2022, respectively.

Acquisition And Disposition

Acquisition And Disposition	12 Months Ended
	Apr. 30, 2023
Acquisition And Disposition [Abstract]
Acquisition And Disposition	NOTE F – ACQUISITION AND DISPOSITION During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into the SPA with Wagz, Buyer and Anderton, pursuant to which the Company sold to Buyer 81 % of the Shares for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a Wagz Loan to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated with effect as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19 % ownership of the shares and Buyer holds a majority 81 % of the shares. See Note P – Discontinued Operations, for more information. On December 31, 2021, the Company acquired 100 % of the stock of Wagz under the terms of the Agreement and Plan of Merger dated July 19, 2021, as amended by the First Amendment to Agreement and Plan of Merger dated December 7, 2021 (the “Merger Agreement”) . Wagz has developed and brought to market a high tech pet collar and has multiple other products in development. Wagz is an internet of things (“IoT”) company which both owns intellectual property and secures recurring revenue through subscriptions for its services. NOTE F – ACQUISITION AND DISPOSITION - Continued Prior to the acquisition, the Company had an investment in Wagz of $ 600,000 , and held Convertible Secured Promissory Notes issued by Wagz of $ 12,000,000 and Secured Promissory Notes issued by Wagz of $ 1,380,705 . Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5 % ownership in Wagz. The Company's 25.5 % equity interest in Wagz common stock was remeasured to fair value of $ 6,299,765 , resulting in a non-cash impairment charge of $ 6,300,235 within the Statements of Operations during fiscal year 2022. Pursuant to the Merger Agreement, 2,443,870 shares of common stock of the Company were issued in the merger for a value of $ 25,245,177 , of which 1,546,592 shares are allocated to Wagz shareholders (excluding the Company) for a total value of $ 15,976,295 , and 897,278 shares are allocated to the Company and treated as treasury stock for a total value of $ 9,268,881 , recorded in the Statements of Changes in Stockholders’ Equity for the fiscal year 2022. The treasury shares were retired as of April 30, 2022. The following table summarizes the consideration for the acquisition of Wagz: Consideration Issuance of 1,546,592 common stock of SigmaTron $ 15,976,295 Fair value of consideration transferred 15,976,295 Secured Promissory Notes 1,380,173 Fair value of SigmaTron's equity interest in Wagz held prior to the business combination (Note B) 6,299,765 $ 23,656,233 The following table presents the purchase price allocation for Wagz. The Company accounted for the acquisition under the acquisition method and is required to measure identifiable assets acquired and liabilities assumed of the acquiree at fair value on the closing date. The fair value of the majority of the assets was determined by a third party valuation firm using management estimates and assumptions including intangible assets of $ 9,730,000 for patents and $ 1,230,000 for trade names. The appropriate fair values of the assets acquired and liabilities assumed are based on estimates and assumptions. The excess consideration was recorded as goodwill of $ 13,320,534 , all of which is non-deductible for tax purposes. Goodwill represents future economic benefits arising from other assets acquired that could not be individually identified including workforce additions, growth opportunities, and increased presence in the Pet Tech market. The recorded goodwill has been assigned to the Pet Tech reportable segment. Cash $ 508,274 Working capital 224,046 Property, plant and equipment 201,839 Acquired intangible assets 10,960,000 Right-of-use operating lease assets 647,076 Other assets 6,000 Operating lease obligations ( 647,077 ) Deferred tax liability ( 215,000 ) Other liabilities ( 1,349,459 ) Goodwill 13,320,534 Fair value of purchase consideration $ 23,656,233 NOTE F – ACQUISITION AND DISPOSITION- Continued The intangible assets acquired in the Wagz acquisition consisted of the following: Expected Weighted Amortization Fair Value Period Trade name $ 1,230,000 20 years Patents 9,730,000 18 years $ 10,960,000 The fair value recorded as of April 30, 2022 is based on significant inputs that are not observable in the market and thus represents a fair value measurement categorized within Level 3 of the fair value hierarchy. The key assumptions used in the fair value estimates under the royalty savings method are revenue and market growth, royalty rates, estimated tax rates, and appropriate risk-adjusted weighted-average cost of capital. These assumptions reflect the Company’s best estimates. The fair value of the acquired trade names and patents was determined using the relief from royalty method, which is a risk-adjusted discounted cash flow approach. The relief from royalty method values an intangible asset by estimating the royalties saved through ownership of the asset. The relief from royalty method requires identifying the future revenue that would be generated by the intangible asset, multiplying it by a royalty rate deemed to be avoided through ownership of the asset and discounting the projected royalty savings amounts back to the acquisition date using the internal rate of return.

Segment And Geographic Area Inf

Segment And Geographic Area Information	12 Months Ended
	Apr. 30, 2023
Segment And Geographic Area Information [Abstract]
Segment And Geographic Area Information	NOTE G – SEGMENT AND GEOGRAPHIC AREA INFORMATION The Company’s reportable segments are strategic business units that offer different products and services. They are managed separately because each business requires different technology and marketing strategies. Separate financial information is regularly evaluated by the Chief Operating Decision Maker (“CODM”) in deciding how to allocate resources. For the Company, the CODM is the Company’s Chief Executive Officer. The EMS reportable segment includes printed circuit board assemblies, electro-mechanical subassemblies and completely assembled (box-build) electronic products. In connection with the production of assembled products, the EMS segment provides services to its customers, including (1) automatic and manual assembly and testing of products; (2) material sourcing and procurement; (3) manufacturing and test engineering support; (4) design services; (5) warehousing and distribution services; (6) assistance in obtaining product approval from governmental and other regulatory bodies and (7) compliance reporting. The EMS segment produces the Freedom Smart Dog Collar™ sold by the Pet Tech segment. The Pet Tech reportable segment offered electronic products such as the Freedom Smart Dog Collar™, a wireless geo-mapped fence and wellness system, along with apparel and accessories. The Pet Tech Segment was sold, effective as of April 1, 2023. The results for the Pet Tech Segment are reported as discontinued operations for fiscal 2023 and fiscal 2022. The accounting policies of the reportable segments are the same as those described in the summary of significant accounting policies in Note-A Description of the Business. The CODM allocates resources to and evaluates the performance of each operating segment based on operating income. NOTE G – SEGMENT AND GEOGRAPHIC AREA INFORMATION - Continued The tables below present information about the Company’s reportable segments. Fiscal Year Ended April 30, 2023 EMS Pet Tech Segment Segment Consolidated Net sales (1) (2) $ 414,435,845 $ 1,598,929 $ 416,034,774 Operating income (loss) (2) 24,957,646 ( 32,887,193 ) ( 7,929,547 ) Other income 632,223 Interest expense, net ( 8,403,904 ) Loss before income taxes $ ( 15,701,228 ) Purchases of machinery and equipment 4,334,169 134,419 4,468,588 Depreciation and amortization 5,817,659 45,877 5,863,536 Identifiable assets $ 268,627,199 $ $ 268,627,199 (1) The EMS segment manufactures products sold to the Pet Tech segment. Related intersegment sales of $ 938,370 have been eliminated. (2) The results for the Pet Tech Segment are reported as discontinued operations for fiscal 2023 and fiscal 2022. Fiscal Year Ended April 30, 2022 EMS Pet Tech Segment Segment Consolidated Net sales (1) (2) $ 378,316,495 $ 549,929 $ 378,866,424 Operating income (loss) (2) 18,409,475 ( 9,180,064 ) 9,229,411 Gain on extinguishment of long-term debt 6,282,973 Other income 153,614 Interest expense, net ( 1,500,140 ) Income before income taxes $ 14,165,858 Purchases of machinery and equipment 4,740,100 9,432 4,749,532 Depreciation and amortization 5,720,157 16,161 5,736,318 Identifiable assets (2) $ 268,350,438 $ 25,280,839 $ 293,631,277 (1) The EMS segment manufactures products sold to the Pet Tech segment. Related intersegment sales of $ 213,298 have been eliminated. (2) The results for the Pet Tech Segment are reported as discontinued operations for fiscal 2023 and fiscal 2022. NOTE G – SEGMENT AND GEOGRAPHIC AREA INFORMATION - Continued The following tables set forth net sales from continuing operations and tangible long-lived assets by geographic area where the Company operates. Tangible long-lived assets include property, plant and equipment and operating lease assets. Fiscal Year Ended April 30, 2023 April 30, 2022 Net sales: U.S. $ 117,389,877 $ 89,119,720 China 48,584,165 46,347,260 Vietnam 11,523,284 13,981,553 Mexico 236,938,519 228,867,962 Total net sales $ 414,435,845 $ 378,316,495 Fiscal Year Ended April 30, 2023 April 30, 2022 Tangible long-lived assets, net: U.S. $ 20,371,298 $ 21,538,417 China 4,212,780 5,060,021 Mexico 17,574,899 18,839,855 Other 854,803 1,286,577 Total tangible long-lived assets, net $ 43,013,780 $ 46,724,870

Intangible Assets

Intangible Assets	12 Months Ended
	Apr. 30, 2023
Intangible Assets [Abstract]
Intangible Assets	NOTE H - INTANGIBLE ASSETS Intangible Assets Intangible assets subject to amortization are summarized as of April 30, 2023 as follows: April 30, 2023 Gross Carrying Accumulated Impairment Write Off Net Intangible Amount Amortization Amount Amount Asset Balance Spitfire: Non-contractual customer relationship 4,690,000 3,378,970 - - 1,311,030 Wagz: Trade name 1,230,000 68,380 813,960 347,660 - Patents 9,730,000 586,313 8,713,813 429,874 - Total $ 15,650,000 $ 4,033,663 $ 9,527,773 $ 777,534 $ 1,311,030 Intangible assets subject to amortization are summarized as of April 30, 2022, as follows: April 30, 2022 Gross Carrying Accumulated Net Intangible Amount Amortization Asset Balance Spitfire: Non-contractual customer relationship 4,690,000 3,039,837 1,650,163 Wagz: Trade name 1,230,000 20,500 1,209,500 Patents 9,730,000 180,185 9,549,815 Less intangible assets of discontinued operations 10,960,000 200,685 10,759,315 $ 4,690,000 $ 3,039,837 $ 1,650,163 NOTE H - INTANGIBLE ASSETS - Continued Estimated aggregate amortization expense for the Company’s intangible assets, which become fully amortized in 2028 , for the remaining fiscal years is as follows: For the fiscal years ending April 30: 2024 $ 331,842 2025 324,702 2026 317,728 2027 310,900 2028 25,858 $ 1,311,030 Amortization expense was $ 339,133 and $ 346,586 for the years ended April 30, 2023 and April 30, 2022, respectively.

Long-Term Debt

Long-Term Debt	12 Months Ended
	Apr. 30, 2023
Long-Term Debt [Abstract]
Long-Term Debt	NOTE I - LONG-TERM DEBT Debt and finance lease obligations consisted of the following at April 30, 2023 and April 30, 2022: 2023 2022 Debt: Notes Payable - Banks $ 90,968,000 $ 56,830,377 Notes Payable - Buildings 417,143 6,459,340 Notes Payable - Equipment 3,524,115 4,202,292 Unamortized deferred financing costs ( 1,608,558 ) ( 401,040 ) Total debt 93,300,700 67,090,969 Less current maturities* 52,761,520 6,991,567 Long-term debt $ 40,539,180 $ 60,099,402 Finance lease obligations $ 4,119,437 $ 4,215,810 Less current maturities 1,523,259 1,410,675 Total finance lease obligations, less current portion $ 2,596,178 $ 2,805,135 * Due to availability being less than 10 % of the Revolving Commitment, the Facility (as defined below) has been classified as a current liability on the Consolidated Balance Sheet as of April 30, 2023. Notes Payable – Secured lenders On January 29, 2021, the Company entered into a Credit Agreement (the “JPM Agreement”) with JPMorgan Chase Bank, N.A. (“Lender” or “JPM”), pursuant to which Lender provided the Company with a secured credit facility consisting of a revolving loan facility and a term loan facility (collectively, the “Facility”). On July 18, 2022, SigmaTron, Wagz and Lender amended and restated the JPM Agreement by entering into an Amended and Restated Credit Agreement (as so amended and restated, the “JPM Credit Agreement”). The Facility, as amended, allows the Company to borrow on a revolving basis up to the lesser of (i) $ 70,000,000 or (ii) an amount equal to a percentage of the eligible receivable borrowing base plus a percentage of the inventory borrowing base minus any reserves established by Lender (the “Revolving Commitment”). The maturity date of the Facility is July 18, 2027. Deferred financing costs of $ 332,139 and $ 128,733 were capitalized during the fiscal year ended April 30, 2023 and April 30, 2022, respectively, which are amortized over the term of the JPM Credit Agreement. As of April NOTE I - LONG-TERM DEBT - Continued Notes Payable – Secured lenders – Continued 30, 2023, there was $ 51,134,699 outstanding and $ 11,539,183 of unused availability under the revolving loan facility compared to an outstanding balance of $ 51,392,158 and $ 5,691,855 of unused availability at April 30, 2022. As of April 30, 2023 and April 30, 2022, the unamortized amount offset against outstanding debt was $ 572,191 and $ 393,503 , respectively. Under the JPM Credit Agreement, a minimum Fixed Charge Coverage Ratio (“FCCR”) financial covenant of 1.10 x is applicable only during an FCCR trigger period which occurs when (a) commencing on the Effective Date (as defined in the JPM Credit Agreement) and ending when the Term Loan Obligations (as defined in the JPM Credit Agreement) have been paid in full and (b) following the payment in full of the Term Loan Obligations, (i) an event of default (as defined in the JPM Credit Agreement) has occurred and is continuing, and Lender has elected to impose a FCCR trigger period upon notice to the Company or (ii) availability falls below the greater of (a) 10 % of the Revolving Commitment and (b) the outstanding principal amount of the term loans. In addition, prior to the amendment to the JPM Credit Agreement pursuant to the JPM Waiver (as discussed below under “ Waiver, Consent and Amendment to Credit Agreements ”), the JPM Credit Agreement imposed a financial covenant that required the Company to maintain a leverage ratio of Total Debt to EBITDA (each as defined in the JPM Credit Agreement) for any twelve month period ending on the last day of a fiscal quarter through the maturity of the revolving Facility not to exceed a certain amount, which ratio (a) ranged from 5.00 -to-1 for fiscal quarters beginning with the fiscal quarter ending on January 31, 2023 to 3.00 -to-1 for the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio (as defined in the JPM Credit Agreement) as of the end of the applicable fiscal quarter is less than or equal to 1.50 -to-1) and (b) ranged from 5.50 -to-1 for the fiscal quarter ending on January 31, 2023 to 4.00 -to-1 for the fiscal quarters beginning with the fiscal quarter ending on July 31, 2026 (if the Term Loan Borrowing Base Coverage Ratio as of the end of the applicable fiscal quarter is greater than 1.50 -to-1). In addition, the JPM Credit Agreement imposes a cash dominion period if there is an event of default or if availability is less than 10 % of the Revolving Commitment, and such requirement continues until there is no event of default and availability is greater than 10 % of the Revolving Commitment, in each case for 30 consecutive days. Based on this criteria, the total debt balances for the Facility must be classified as a current liability on the Consolidated Balance Sheet as of April 30, 2023. In connection with the entry into the JPM Credit Agreement, Lender and TCW Asset Management Company LLC, as administrative agent under the Term Loan Agreement (as defined below), entered into the Intercreditor Agreement, dated July 18, 2022, and acknowledged by SigmaTron and Wagz (the “ICA”), to set forth and govern the lenders’ respective lien priorities, rights and remedies under the JPM Credit Agreement and the Term Loan Agreement. The Facility under the JPM Credit Agreement is secured by: (a) a first priority security interest in SigmaTron’s and Wagz’s (i) accounts receivable and inventory (excluding Term Priority Mexican Inventory (as defined in the ICA) and certain inventory in transit, (ii) deposit accounts, (iii) proceeds of business interruption insurance that constitute ABL BI Insurance Share (as defined in the ICA), (iv) certain other property, including payment intangibles, instruments, equipment, software and hardware and similar systems, books and records, to the extent related to the foregoing, and (v) all proceeds of the foregoing, in each case, now owned or hereafter acquired (collectively, the “ABL Priority Collateral”); and (b) a second priority security interest in Term Priority Collateral (as defined below) other than (i) real estate and (ii) the equity interests of SigmaTron’s foreign subsidiaries (unless such a pledge is requested by Lender). On April 25, 2022, the Company and Lender, entered into an amendment of the Facility. Under the amended Facility, Lender extended a term loan to the Company in the principal amount of $ 5,000,000 (the “FILO Term Loan”), the interest on which is based on (i) the “ Adjusted Term SOFR Rate” for a one-month Interest Period (each, as defined in NOTE I - LONG-TERM DEBT - Continued Notes Payable – Secured lenders – Continued the Agreement), plus (ii) an applicable margin of 4.0 % (effectively 4.41 % per annum at April 30, 2022). The FILO Term Loan will mature within 120 days from the date of the amendment. The amount outstanding as of April 30, 2022 was $ 5,000,000 . There were no issuance costs associated with the FILO Term Loan. On July 18, 2022, a portion of the proceeds of the Term Loan Agreement (as defined below) was used to pay in full the FILO Term Loan extended by Lender. On July 18, 2022, SigmaTron, Wagz and TCW Asset Management Company LLC, as administrative agent, and other Lenders party thereto (collectively, “TCW”) entered into a Credit Agreement (the “Term Loan Agreement”) pursuant to which TCW made a term loan to the Company in the principal amount of $ 40,000,000 (the “TCW Term Loan”). The TCW Term Loan bears interest at a rate per annum based on SOFR, plus the Applicable Margin of 7.50 % (each as defined in the Term Loan Agreement). The TCW Term Loan has a SOFR floor of 1.00 %. The maturity date of the TCW Term Loan is July 18, 2027 . The amount outstanding as of April 30, 2023, was $ 43,867,135 . Deferred financing costs of $ 1,233,894 were capitalized during the fiscal year ended April 30, 2023. As of April 30, 2023, the unamortized amount offset against outstanding debt was $ 1,036,367 . The Term Loan Agreement imposes financial covenants, including covenants requiring the Company to maintain a minimum Fixed Charge Coverage Ratio (as defined in the Term Loan Agreement) of 1.10 -to-1 and maintain the same leverage ratio of Total Debt to EBITDA as described above under the JPM Credit Agreement. The Company is required to make quarterly repayments of the principal amount of the TCW Term Loan in amounts equal to $ 250,000 per fiscal quarter for the quarters beginning October 31, 2022 and $ 500,000 per fiscal quarter for quarters beginning October 31, 2024. The Term Loan Agreement also requires mandatory annual repayments equal to 50 % of Excess Cash Flow (as defined in the Term Loan Agreement). The TCW Term Loan is secured by: (a) a first priority security interest in all property of SigmaTron and Wagz that does not constitute ABL Priority Collateral, which includes: (i) SigmaTron’s and Wagz’s real estate other than SigmaTron’s Del Rio, Texas, warehouses, (ii) SigmaTron’s and Wagz’s machinery, equipment and fixtures (but excluding ABL Priority Equipment (as defined in the ICA)) , (iii) the Term Priority Mexican Inventory (as defined in the ICA), (iv) SigmaTron’s stock in its direct and indirect subsidiaries, (v) SigmaTron’s and Wagz’s general intangibles (excluding any that constitute ABL Priority Collateral), goodwill and intellectual property, (vi) the proceeds of business interruption insurance that constitute Term BI Insurance Share (as defined in the ICA) , (vii) tax refunds, and (viii) all proceeds thereof, in each case, now owned or hereafter acquired (collectively, the “Term Priority Collateral”); and (b) a second priority security interest in all collateral that constitutes ABL Priority Collateral. Also, SigmaTron’s three Mexican subsidiaries pledged all of their assets as security for the TCW Term Loan. Waiver, Consent and Amendment to Credit Agreements On March 2, 2023, the Company received notices of default from both JPM and TCW. T he Notices indicated the occurrence of certain events of default under the JPM Credit Agreement and the Term Loan Agreement ( together with the JPM Credit Agreement the “Credit Agreements”). In addition, the Company received a delinquency notification letter from Nasdaq indicating that the Company was not in compliance with the continued listing requirements of Nasdaq for failing to timely file the Company ’ s F o rm 10-Q for the fiscal quarter ended January 31, 2023. This notification also constituted a default under the Credit Agreements. The delinquency was remedied on May 19, 2023. The JPM Notice indicated that the Lender was informed of the occurrence of events of defaults and the continuation thereof under the JPM Credit Agreement as a result of the Company’s failure to maintain a FCCR for the twelve month period ending January 31, 2023 of at least 1.10 x as required under the JPM Credit Agreement (the “JPM Covenant Defaults”). NOTE I - LONG-TERM DEBT - Continued Notes Payable – Secured lenders - Continued The TCW Notice indicated that Agent and TCW Lenders were informed of the occurrence of events of default and the continuation thereof under the Term Loan Agreement (described below) as a result of the Company permitting the Total Debt to EBITDA Ratio for the twelve month period ending on January 31, 2023 to be greater than 5.00 :1.00 in violation of the Term Loan Agreement and the Company’s failure to maintain FCCR as required under the JPM Credit Agreement (the “TCW Covenant Defaults” and together with the JPM Covenant Defaults, the “Defaults”). As a result of the Defaults, the Company was not in compliance with its financial covenants under the Credit Agreements as of January 31, 2023. Due to the Notices received on March 2, 2023, from each of JPM and the TCW Lenders and Agent, the total debt balances for both the Facility and the TCW Term Loan had been classified as a current liability on the Condensed Consolidated Balance Sheet on January 31, 2023. On April 28, 2023, the Company entered into (i) a W aive r , Consent and Amendment No. 1 to the JPM Credit Agreement (“JPM W aiver”) with W agz and JPM, as l e nder , which waived certain events of default under and amended certain terms of the JPM Credit Agreement and (i i ) a W aive r , Consent and Amendment No. 1 to the Credit Agreement (“TCW W aiver”) with W agz, the financial institutions identifi e d therein (the “TCW Lenders”) and TCW Asset Management Company LLC as administrative agent for the TCW Lenders (in such capacit y , the “Agent” and collectively with the TCW Lenders and JPM, the “Lender Parties”), which waived certain events of default under and amended certain terms of the Credit Agreements. The Company entered into the JPM W aiver and TCW W aiver (togethe r , the “ W aivers”) after receiving on March 2, 2023, the Notices from each of JPM and the TCW Lenders and Agent. The Notices indicated the occurrence of certain events of default under the Credit Agreements. T he Company was in compliance with its financial covenants under the Credit Agreements as of April 30, 2023. Pursuant to the W aivers, the Company has agreed, among other things, to (i) if requested by the Agent, e f fect a corporate restructuring that would create a new holding company structure to own all of the Company ’ s stock through a me r ger pursuant to Section 251(g) of the General Corporation Law of the State of Delaware, after which the holding c o mpany would continue as the public compan y , become a guarantor under the Credit Agreements and pledge to the Lender Parties all of the equity of the Compan y (the “Corporate Restructuring”), (ii) engage a financial advisor to review certain of the Company ’ s financial reporting to JPM and the Agent and participate in weekly confer e nce calls with the adviso r , JPM and the Agent to discuss and provide updates on the Company ’ s liquidity and operations, (iii) extend the W agz Loan, (iv) pay to JPM an amendment fee in the amount of $ 70,000 , paid in cash, and (v) pay to the TCW Lenders an amendment fee of $ 395,000 and a default rate fee of $ 188,301 , both of which were paid in kind by being added to the principal of the TCW Term Loan. The W aivers also amended the Credit Agreements to, among other things, (x) require that the Company maintain a minimum of $ 2.5 mil l ion in revolver availability under the JPM Credit Agreement, (y) modify the definition of EBITDA to allow adjustments to account for W agz oper a ting losses, impairment cha r ges relating to the write-down of the W agz business, the Wagz Loan and net assets of the Com p any and W agz, and expenses relating to the W aivers, the W agz sale and S P A, and (z) modify the existing T otal Debt to EBITDA R a tios (as defined in the Credit Agreements) as follows: NOTE I - LONG-TERM DEBT - Continued Notes Payable – Secured lenders - Continued Fiscal Quarter Total Debt to EBITDA Ratio* (as amended) Total Debt to EBITDA Ratio* (prior to amendment) October 31,2023 4.50 :1.0 4.25 :1.0 January 31, 2024 4.50 :1.0 4.00 :1.0 April 30, 2024 4.50 :1.0 4.00 :1.0 July 31, 2024 4.25 :1.0 3.75 :1.0 October 31, 2024 4.00 :1.0 3.75 :1.0 * Assumes the T erm Loan Borrowing Base Coverage Ratio (as defined in the Credit Agreements) is less than or equal to 1.50:1.0. In addition, pursuant to the TCW Waiver, if the Total Debt to EBITDA Ratio for the trailing twelve month period as of the end o f the third quarter of fiscal 2023 exceeds the ratios that were in e f fect prior to the amendment (as set forth in the far right column of the table above) for a fiscal quarter during the PIK Period (defined in the Term Loan Agreement ), then the Applicable Ma r gin under t he Term Loan Agreement in respect of the outstanding TCW Term Loan would increase by an amount equal to 1.0 % per annum for the fiscal quarte r , with such interest being paid in kind. Furthermore, the JPM W aiver modified the definition of Applicable Ma r gin from a fixed amount equal to 2.00 % to an amount that varies from 2.00 % (for revolver availability greater than or equal to $ 20.0 million), to 2.50 % (for revolver availability greater than or equal to $ 10.0 million), to 3.00 % (for revolver availability less than $ 10.0 million), and fixed the Applicable Ma r gin at 3.00 % for six months starting April 1, 2023. In exchange for such agreements, the Lender Parties have agreed to waive all of the existing events of default under the Credit Agreements through March 31, 2023, consent to the sale of W agz and release W agz and its property and the Company ’ s 81 % interest in W agz that was sold to Buyer (as disclosed below) from the lien of the Lender Parties. In connection with the W aivers, the Company exited its active involvement in the Pet T ech business that is conducted b y W agz through the sale by the Company of a majority stake in W agz, effective as of April 1, 2023. On June 15, 2023, the Company entered into (i) Amendment No. 2 to the Credit Agreement (the “JPM Amendment No. 2”) by and among the Company and Lender, with respect to the JPM Credit Agreement and (ii) Amendment No. 2 to the Credit Agreement (“TCW Amendment No. 2”) by and among the Company, the TCW Lenders and the Agent with respect to the Term Loan Agreement. The JPM Amendment No. 2 and TCW Amendment No. 2 (together, the “Amendments”) amend the Credit Agreements to extend the date, from May 31, 2023 to July 31, 2023, after which the Agent may request that the Company effect the Corporate Restructuring. On April 23, 2020, the Company received a PPP Loan from U.S. Bank, as lender, pursuant to the Paycheck Protection Program of the CARES Act, as administered by the U.S. Small Business Administration (the “SBA”) in the amount of $ 6,282,973 (the “PPP Loan”). The PPP Loan was scheduled to mature on April 23, 2022. The Company was notified of the forgiveness of the PPP Loan by the SBA on July 9, 2021 and all principal and accrued interest were forgiven. The accounting for the forgiveness is reflected in the Company’s Statement of Operations for fiscal 2022 as a non-cash gain upon extinguishment of long-term debt. NOTE I - LONG-TERM DEBT – Continued Notes Payable – Secured lenders - Continued On March 15, 2019, the Company’s wholly-owned foreign enterprise, Wujiang SigmaTron Electronic Technology Co., Ltd., entered into a credit facility with China Construction Bank. On January 26, 2021, the agreement was amended and expired in accordance with its terms on January 6, 2022 . On January 17, 2022, the agreement was renewed, and expired in accordance with its terms on December 23, 2022 . On February 17, 2023, the agreement was renewed, and is scheduled to expire on February 7, 2024 . Under the agreement Wujiang SigmaTron Electronic Technology Co., Ltd. can borrow up to 10,000,000 Renminbi, approximately $ 1,444,252 as of April 30, 2023, and the facility is collateralized by Wujiang SigmaTron Electronics Co., Ltd.’s manufacturing building. Interest is payable monthly and the facility bears a fixed interest rate of 3.35 % per annum. There was no outstanding balance under the facility at April 30, 2023 compared to an outstanding balance of $ 438,219 at April 30, 2022. Notes Payable – Buildings The Facility also included two term loans, in the aggregate principal amount of $ 6,500,000 . A final aggregate payment of approximately $ 4,368,444 was due on or before January 29, 2026 . On July 18, 2022, a portion of the proceeds of the TCW Term Loan was used to pay in full both term loans extended by Lender. There was no outstanding balance at April 30, 2023 compared to an outstanding balance of $ 5,994,445 at April 30, 2022. The Company entered into a mortgage agreement on March 3, 2020, in the amount of $ 556,000 , with The Bank and Trust SSB to finance the purchase of the property that serves as the Company’s warehousing and distribution center in Del Rio, Texas. The note requires the Company to pay monthly installment payments in the amount of $ 6,103 . Interest accrues at a fixed rate of 5.75 % per year until March 3, 2025, and adjusts thereafter, on an annual basis, equal to 1.0 % over the Prime Rate as published by The Wall Street Journal. The note is payable over a 120 month period. The outstanding balance was $ 417,143 and $ 464,895 at April 30, 2023 and April 30, 2022, respectively. Notes Payable - Equipment The Company routinely entered into secured note agreements with Engencap Fin S.A. DE C.V. to finance the purchase of equipment. The terms of the outstanding secured note agreement mature on May 1, 2023 , with a final quarterly installment payment of $ 9,310 and a fixed interest rate of 8.00 % per annum. The Company routinely enters into secured note agreements with FGI Equipment Finance LLC to finance the purchase of equipment. The terms of the outstanding secured note agreements mature from March 2025 through October 2027 , with quarterly installment payments ranging from $ 10,723 to $ 69,439 and a fixed interest rate ranging from 8.25 % to 9.25 % per annum. NOTE I - LONG-TERM DEBT – Continued Notes Payable – Equipment - Continued Annual maturities of the Company’s debt, net of deferred financing fees for each of the next five years and thereafter, as of April 30, 2023, are as follows: Fiscal Year Bank Building Equipment Total 2024 $ 51,562,508 $ 50,571 $ 1,148,441 $ 52,761,520 2025 1,501,272 53,557 1,176,986 2,731,815 2026 1,751,272 56,719 841,614 2,649,605 2027 1,751,272 60,068 291,085 2,102,425 2028 32,793,118 63,614 65,989 32,922,721 Thereafter - 132,614 - 132,614 $ 89,359,442 $ 417,143 $ 3,524,115 $ 93,300,700 * Due to availability being less than 10% of the Revolving Commitment, the Facility (as defined above) has been classified as a current liability on the Consolidated Balance Sheet as of April 30, 2023. The maturity date of both the Facility and the TCW Term Loan is July 18, 2027 with an outstanding balance of $ 89,359,442 . Finance Lease and Sales Leaseback Obligations The Company enters into various finance lease and sales leaseback agreements. The terms of the outstanding lease agreements mature through April 1, 2027 , with monthly installment payments ranging from $ 2,874 to $ 33,706 and a fixed interest rate ranging from 7.09 % to 12.73 % per annum. Annual future minimum obligations under outstanding finance leases and sale leaseback agreements for each of the next five fiscal years and thereafter, as of April 30, 2023, are as follows: Fiscal Year Total 2024 $ 1,856,501 2025 1,674,988 2026 1,007,719 2027 177,772 2028 - Total minimum lease payments 4,716,980 Less: Amounts representing interest 597,543 Present value of net minimum lease payments $ 4,119,437 Other Long-Term Liabilities As of April 30, 2023 and April 30, 2022 the Company had recorded $ 100,350 and $ 1,051,587 , respectively, for seniority premiums of which none and $ 957,528 , respectively, were for retirement accounts related to benefits for employees of the Company’s foreign subsidiaries.

Accrued Expenses And Wages

Accrued Expenses And Wages	12 Months Ended
	Apr. 30, 2023
Accrued Expenses And Wages [Abstract]
Accrued Expenses And Wages	NOTE J - ACCRUED EXPENSES AND WAGES Accrued expenses consist of the following at April 30: 2023 2022 Interest $ 505,423 $ 156,776 Commissions 193,480 141,008 Professional fees 268,526 475,761 Other - Purchases 359,647 852,862 Other 1,606,354 1,126,695 $ 2,933,430 $ 2,753,102 Accrued wages consist of the following at April 30: 2023 2022 Domestic wages $ 2,184,469 $ 2,597,312 Bonuses 2,282,927 3,624,794 Foreign wages 3,449,870 2,855,743 $ 7,917,266 $ 9,077,849

Income Tax

Income Tax	12 Months Ended
	Apr. 30, 2023
Income Tax [Abstract]
Income Tax	NOTE K - INCOME TAX U.S. and foreign income before income (loss) tax expense for the fiscal years ended April 30 are as follows: 2023 2022 Domestic $ 11,138,944 $ 19,155,489 Foreign 6,047,021 4,190,433 $ 17,185,965 $ 23,345,922 Income Tax Provision The income tax expense for the fiscal years ended April 30 consists of the following: 2023 2022 Current Federal $ 3,219,203 $ 2,255,406 State 742,275 560,436 Foreign 1,392,834 1,010,149 Total Current 5,354,312 3,825,991 Deferred Federal ( 2,282,300 ) 1,315,037 State ( 459,788 ) 326,217 Foreign 379,317 ( 487,242 ) Total Deferred ( 2,362,771 ) 1,154,012 Income tax $ 2,991,541 $ 4,980,003 NOTE K - INCOME TAX - Continued Income Tax Provision - Continued The difference between the income tax expense and the amounts computed by applying the statutory Federal income tax rates to income from continuing operations before tax expense for the fiscal years ended April 30 are as follows: 2023 2022 U.S Federal Provision: At statutory rate $ 3,609,047 $ 4,902,642 State taxes ( 1,007,854 ) 521,668 Change in valuation allowance 5,909,955 1,179,616 Benefit of NOL carryforward ( 428,662 ) ( 130,834 ) Foreign tax differential 477,375 338,435 Impact of state tax rate change ( 3,177 ) 7,622 Global intangible low tax inclusion 135,721 - Foreign valuation allowance 45,278 ( 663,025 ) Impact of foreign permanent items other non deductible items 142,303 311,172 PPP loan forgiveness income - ( 1,334,901 ) Investment in subsidiary ( 5,694,916 ) - Tax credits and other permanent differences ( 76,654 ) - Foreign currency exchange (gain)/loss in local jurisdiction ( 47,951 ) 51,179 Foreign inflation adjustment ( 78,625 ) ( 107,608 ) Stock-based compensation 9,701 ( 95,963 ) Provision for income taxes $ 2,991,541 $ 4,980,003 NOTE K - INCOME TAX - Continued Deferred Tax Assets and Liabilities Deferred income taxes reflect the net tax effects of loss and credit carryforwards and temporary differences between the carrying amounts of assets and liabilities for financial reporting purposes and the amounts used for income tax purposes. Significant components of the deferred tax assets and liabilities for federal, state and foreign income taxes are as follows: 2023 2022 Deferred Tax Assets Federal, foreign & state NOL carryforwards $ 464,828 $ 822,140 Research and other credits 78,100 78,100 Other intangibles - US 443,460 527,469 Property, plant & equipment - 113,338 Reserves and accruals 1,428,485 1,222,395 Stock-based compensation 452,858 426,655 Capital loss carryforward 5,833,375 - Inventory 3,153,198 2,703,370 Interest expense carryforward 1,009,274 - Lease liabilities 2,079,443 2,909,748 Allowance for doubtful accounts 25,360 25,490 Other intangibles - foreign - 11,536 Investment in subsidiary 1,349,152 - Other 34,065 66,231 Federal benefit of state taxes - 16,800 Total gross deferred tax assets 16,351,598 8,923,272 Less: valuation allowance 7,703,517 1,703,141 Net deferred tax assets $ 8,648,081 $ 7,220,131 Deferred Tax Liabilities Property, machinery & equipment $ ( 3,641,468 ) $ ( 3,488,320 ) Prepaids ( 329,062 ) ( 459,588 ) Operating Lease right-of-use assets ( 1,956,894 ) ( 2,779,092 ) Federal benefit of state taxes ( 79,755 ) - Total deferred tax liabilities $ ( 6,007,179 ) $ ( 6,727,000 ) Deferred tax asset $ 2,640,902 $ 856,863 Deferred tax liability - ( 363,732 ) Net deferred tax asset $ 2,640,902 $ 493,131 NOTE K - INCOME TAX - Continued Deferred Tax Assets and Liabilities - Continued The CARES Act was signed into law by the President of the U.S. on March 27, 2020. This legislation is aimed at providing relief for individuals and businesses impacted by the COVID-19 outbreak. The CARES Act includes several significant business tax provisions that, among other things, would temporarily eliminate the taxable income limit for certain net operating losses (NOL), allow businesses to carry back NOLs arising in 2018, 2019, and 2020 to the five prior tax years, accelerate refunds of corporate Alternative Minimum Tax credits, temporarily increase the business interest limitation under section 163(j), and allow for deferral of payroll taxes. The CARES Act also established the PPP, to be administered by the SBA, whereby certain businesses are eligible for a loan to fund payroll expenses, rent, and related costs. The PPP Loan may be forgiven if the funds are used for payroll and other qualified expenses within certain limits. As described in Note I – Long-Term Debt, the Company received a PPP Loan under the CARES Act of $ 6,282,973 . For federal income tax purposes, the CARES Act expressly provides that any forgiveness or cancellation of all or part of such loans will not be treated as income for tax purposes. On January 6, 2021 the IRS issued Revenue Ruling 2021-02 allowing deductions for the payments of eligible expenses when such payments would result in the forgiveness of a loan under the PPP. The ruling supersedes previous IRS guidance stating that such deductions would be disallowed. The Company received full forgiveness of its PPP Loan on July 9, 2021. In accordance with the CARES Act and IRS Revenue Ruling 2021-02, the loan forgiveness amount was excluded from income for tax purposes in fiscal year 2022. The Company has foreign NOL carryforwards of approximately $ 2,302,000 as of April 30, 2023, which will begin to expire in 2024 . The Company recognizes a valuation allowance if, based on the weight of available evidence, it is more likely than not that some portion, or all, of a deferred tax asset will not be realized. SigmaTron and Wagz filed or are expected to file U.S. tax returns on a consolidated basis for periods during which Wagz was wholly owned. Therefore, a valuation allowance was previously established on the group’s U.S. deferred tax assets during fiscal year 2022. After the sale of Wagz, SigmaTron expects to file on a standalone basis and utilize its U.S. deferred tax assets with the exception of the capital loss on sale, its investment in subsidiary, and certain foreign tax credits. The Company has established a valuation allowance of $ 7,260,628 on its U.S. capital loss, its investment in subsidiary, and foreign tax credit carryforwards. The Company has also established a valuation allowance of $ 442,889 on NOLs attributable to its Vietnam subsidiary as of April 30, 2023. Based on historical losses and forecasted future earnings, the Company has determined that the tax benefit from such assets are not more likely than not to be realized. Cash and cash equivalents held internationally may be subject to foreign withholding taxes if repatriated to the U.S. Absent meeting an exception, unrepatriated foreign earnings generally remain subject to local country withholding taxes upon repatriation. The Company continues to apply its permanent reinvestment assertion on the cumulative amount of unremitted earnings of approximately $ 11,822,000 as of April 30, 2023, from its foreign subsidiaries. NOTE K - INCOME TAX - Continued Unrecognized Tax Benefits The Company has not identified any uncertain tax positions to be taken in the Company’s tax returns. For the fiscal years ended April 30, 2023 and April 30, 2022, the amount of consolidated worldwide liability for uncertain tax positions that impacted the Company’s effective tax rate was $ 0 . Other Interest and penalties related to tax positions taken in the Company’s tax returns are recorded in income tax expense and selling and administrative expenses, respectively, in the Company’s Consolidated Statements of Operations. For the fiscal years ended April 30, 2023 and April 30, 2022, the amount included in the Company’s Consolidated Balance Sheet for such liabilities was $ 0 . The Company is subject to taxation in the U.S. and various state and foreign jurisdictions. With few exceptions, the Company is no longer subject to state, local or foreign examinations by tax authorities for tax years before fiscal year 2017.

401(k) Retirement Savings Plan

401(k) Retirement Savings Plan	12 Months Ended
	Apr. 30, 2023
401(k) Retirement Savings Plan [Abstract]
401(k) Retirement Savings Plan	NOTE L - 401(k) RETIREMENT SAVINGS PLAN The Company sponsors 401(k) retirement savings plans, which are available to all non-union U.S. employees. The Company may elect to match 25.0 % of the first 5.0 % participant contributions up to $ 2,000 per participant annually. The Company contributed $ 204,924 and $ 199,054 to the plans during the fiscal years ended April 30, 2023 and April 30, 2022 , respectively. The Company incurred total expenses of $ 17,325 and $ 20,280 for the fiscal years ended April 30, 2023 and April 30, 2022, respectively, relating to costs associated with the administration of the plans.

Major Customers And Concentrati

Major Customers And Concentration Of Credit Risk	12 Months Ended
	Apr. 30, 2023
Major Customers And Concentration Of Credit Risk [Abstract]
Major Customers And Concentration Of Credit Risk	NOTE M - MAJOR CUSTOMERS AND CONCENTRATION OF CREDIT RISK Financial instruments that potentially subject the Company to concentration of credit risk consist principally of uncollateralized accounts receivable. For the fiscal year ended April 30, 2023, the Company’s largest customer accounted for 13.4 % of the Company’s net sales and and 6.8 % of accounts receivable. For the fiscal year ended April 30, 2022, the Company’s largest customer accounted for 21.8 % of the Company’s net sales and 4.0 % of accounts receivable. Further, the Company has $ 404,741 in cash in China as of April 30, 2023. Effective May 1, 2015, China implemented a deposit insurance program to insure up to approximately $ 81,000 in deposits under certain circumstances. Funds above this amount are not insured by a guaranteed deposit insurance system. Under the Federal Deposit Insurance Corporation (“FDIC”) program, deposit insurance insures up to $ 250,000 held in participating U.S. banks.

Leases

Leases	12 Months Ended
	Apr. 30, 2023
Leases [Abstract]
Leases	NOTE N - LEASES The Company leases office and storage space, vehicles and other equipment under non-cancellable operating leases with initial terms typically ranging from 1 to 5 years. At contract inception, the Company reviews the facts and circumstances of the arrangement to determine if the contract is or contains a lease. The Company follows the guidance in Topic 842 to evaluate whether the contract has an identified asset; if the Company has the right to obtain substantially all economic benefits from the asset; and if the Company has the right to direct the use of the underlying asset. When determining if a contract has an identified asset, the Company considers both explicit and implicit assets, and whether the supplier has the right to substitute the asset. When determining if the Company has the right to direct the use of an underlying asset, the Company considers if it has the right to direct how and for what purpose the asset is used throughout the period of use and if it controls the decision-making rights over the asset. The Company’s lease terms may include options to extend or terminate the lease. The Company exercises judgment to determine the term of those leases when extension or termination options are present and includes such options in the calculation of the lease term when it is reasonably certain that it will exercise those options. The Company has elected to include both lease and non-lease components in the determination of lease payments. Payments made to a lessor for items such as taxes, insurance, common area maintenance, or other costs commonly referred to as executory costs, are also included in lease payments if they are fixed. The fixed portion of these payments are included in the calculation of the lease liability, while any variable portion would be recognized as variable lease expenses, when incurred. Variable payments made to third parties for these, or similar costs, such as utilities, are not included in the calculation of lease payments. At commencement, lease-related assets and liabilities are measured at the present value of future lease payments over the lease term. As most of the Company’s leases do not provide an implicit rate, the Company exercises judgment in determining the incremental borrowing rate based on the information available when the lease commences to measure the present value of future payments. Operating lease expense is recognized on a straight-line basis over the lease term. Finance lease cost includes amortization, which is recognized on a straight-line basis over the expected life of the leased asset, and interest expense, which is recognized following an effective interest rate method. Operating leases are included in other assets, current operating lease obligations, and operating lease obligations (less current portion) on the Company’s Consolidated Balance Sheet. Finance leases are included in property, plant and equipment and current and long-term portion of finance lease obligations on the Company’s Consolidated Balance Sheet. Short term leases with an initial term of 12 months or less are not presented on the balance sheet with expense recognized as incurred. NOTE N - LEASES – Continued The following table presents lease assets and liabilities and their balance sheet classification: April 30, April 30, Classification 2023 2022 Operating Leases: Right-of-use Assets Right-of-use assets $ 7,225,423 $ 10,946,764 Operating lease current liabilities Current portion of operating lease obligations 2,908,213 3,508,864 Operating lease noncurrent liabilities Operating lease obligations, less current portion 4,723,867 7,903,898 Finance Leases: Right-of-use Assets Property, machinery and equipment 5,294,097 5,561,243 Finance lease current liabilities Current portion of finance lease obligations 1,523,259 1,410,675 Finance lease noncurrent liabilities Finance lease obligations, less current portion 2,596,178 2,805,135 The components of lease expense for the fiscal years ended April 30, 2023 and 2022 are as follows: April 30, April 30, Classification 2023 2022 Operating Leases: Operating lease cost Cost of products sold 2,544,415 2,403,465 Variable lease cost Cost of products sold 223,431 216,042 Short term lease cost Cost of products sold 9,000 7,200 Finance Leases: Amortization of right-of-use assets Cost of products sold 2,369,642 2,275,169 Interest expense Interest expense, net 414,863 293,334 Total 5,561,351 5,195,210 The weighted average lease term and discount rates for the fiscal years ended April 30, 2023 and 2022 are as follows: April 30, April 30, 2023 2022 Operating Leases: Weighted average remaining lease term (months) 36.3 45.9 Weighted average discount rate 3.3 % 3.2 % Finance Leases: Weighted average remaining lease term (months) 31.79 36.21 Weighted average discount rate 9.8 % 9.5 % NOTE N - LEASES – Continued Future payments due under leases reconciled to lease liabilities are as follows: Operating Leases Finance Leases For the fiscal years ending April 30: 2024 2,974,745 1,856,501 2025 2,450,683 1,674,988 2026 1,921,052 1,007,719 2027 343,006 177,772 2028 74,382 - Thereafter 63,717 - Total undiscounted lease payments 7,827,585 4,716,980 Present value discount, less interest 195,505 597,543 Lease liability $ 7,632,080 $ 4,119,437 Supplemental disclosures of cash flow information related to leases as of fiscal years ended April 30, 2023 and 2022 are as follows: April 30, April 30, Other Information 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from finance leases 414,863 293,334 Operating cash flows from operating leases 316,434 382,044 Financing cash flows from finance leases 1,695,829 1,855,822 Supplemental non-cash information on lease labilities arising from obtaining right-of-use assets: Right-of-use assets obtained in exchange for new finance lease liabilities 1,599,456 3,435,498 Right-of-use assets obtained in exchange for operating lease liabilities 3,721,341 2,716,298

Stock Compensation And Equity T

Stock Compensation And Equity Transactions	12 Months Ended
	Apr. 30, 2023
Stock Compensation And Equity Transactions [Abstract]
Stock Compensation And Equity Transactions	NOTE O - STOCK COMPENSATION AND EQUITY TRANSACTIONS The Company has stock option plans (“Option Plans”) under which certain employees may acquire shares of SigmaTron’s common stock. All Option Plans have been approved by SigmaTron’s stockholders. At April 30, 2023, the Company has 187,900 shares available for future issuance to employees under the employee plans. The Option Plans are interpreted and administered by the Compensation Committee of SigmaTron’s Board of Directors. The maximum term of options granted under the Option Plans is generally 10 years. Options granted under the Option Plans are either incentive stock options or nonqualified options. Each option under the Option Plans is exercisable for one share of stock. Options forfeited under the Option Plans are available for reissuance. Options granted under these plans are granted at an exercise price equal to the fair market value of a share of SigmaTron’s common stock on the date of grant using the Black-Scholes option pricing model. There were no options for shares of the Company’s common stock granted to employees in fiscal 2023. The Company granted 102,000 options for shares of SigmaTron’s common stock to employees in the first quarter of fiscal year 2022, which fully vested in six months . The Company recognized approximately $ 245,770 in compensation expense in fiscal year 2022. There was no unrecognized compensation expense as of April 30, 2022. The Company estimated the fair value of these stock options on the date of the grant using the Black-Sholes option pricing model with the following assumptions: 2019 Option Plan Fiscal 2022 Awards Expected volatility 57.0 % Risk-free interest rate 0.93 % Expected life of options (in years) 5.25 Grant date fair value $ 4.83 Expected volatility was based on the monthly changes in SigmaTron’s historical common stock prices over the expected life of the award. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of the grant corresponding to the expected life of the options. The expected life of options is based on the terms of the options. The Company authorized 400,000 shares under the Option Plans in fiscal year 2022. The Company granted 362,500 options for shares of SigmaTron’s common stock to employees in the fourth quarter of fiscal year 2022, of which 25 % vested immediately, 25 % vested during the fourth quarter of fiscal year 2023 and 25 % will vest each year for the next two years . During fiscal year 2023, there were 138,750 forfeited options for shares. The Company recognized $ 184,343 and $ 376,474 in compensation expense in fiscal year 2023 and 2022, respectively. There was $ 368,685 and $ 1,129,423 of unrecognized compensation expense as of April 30, 2023 and April 30, 2022, respectively. The Company estimated the fair value of these stock options on the date of the grant using the Black-Sholes option pricing model with the following assumptions: 2021 Option Plan Fiscal 2022 Awards Expected volatility 67.0 % Risk-free interest rate 2.93 % Expected life of options (in years) 6.00 Grant date fair value $ 6.66 Expected volatility was based on the monthly changes in SigmaTron’s historical common stock prices over the expected life of the award. The risk-free interest rate is based on the U.S. Treasury yield curve in effect at the time of NOTE O - STOCK COMPENSATION AND EQUITY TRANSACTIONS – Continued the grant corresponding to the expected life of the options. The expected life of options is based on the terms of the options. The Company has a restricted stock plan under which non-employee directors may acquire shares of SigmaTron’s common stock. The restricted stock plan has been approved by SigmaTron’s stockholders. At April 30, 2023, the Company has 40,000 shares available for future issuance under the non-employee director plan. The restricted stock plan is interpreted and administered by the Compensation Committee of SigmaTron’s Board of Directors. All awarded stock under the plan vests in six months from the date of grant. Awarded stock under this plan is granted at the closing price of SigmaTron’s common stock on the date of grant. In July 2021, the Company issued 7,500 shares of restricted SigmaTron common stock pursuant to the 2018 Non-Employee Director Restricted Stock Plan, which fully vested on January 8, 2022. The Company recognized $ 37,125 in compensation expense in fiscal year 2022. The aggregate grant date fair value of restricted stock awards granted in July 2021 was computed in accordance with FASB ASC Topic 718. In January 2022, the Company issued 15,000 shares of restricted SigmaTron common stock pursuant to the 2021 Non-Employee Director Restricted Stock Plan, which fully vested on July 8, 2022. The Company recognized $ 49,873 and $ 81,675 in compensation expense in fiscal year 2023 and 2022, respectively. The balance of unrecognized compensation expense related to the Company’s restricted stock award was $ 0 and $ 49,873 at April 30, 2023 and 2022, respectively. The aggregate grant date fair value of restricted stock awards granted in January 2022 was computed in accordance with FASB ASC Topic 718. In September 2022, the Company issued 20,000 shares of restricted SigmaTron common stock pursuant to the 2021 Non-Employee Director Restricted Stock Plan, which fully vested on March 29, 2023. The Company recognized $ 98,199 in compensation expense in fiscal year 2023. There was no balance of unrecognized compensation expense related to the Company’s restricted stock award at April 30, 2023. The aggregate grant date fair value of restricted stock awards granted in September 2022 was computed in accordance with FASB ASC Topic 718. NOTE O - STOCK COMPENSATION AND EQUITY TRANSACTIONS – Continued The table below summarizes option activity through April 30, 2023: Number of Number of securities to be Weighted- options issued upon average exercisable exercise of exercise at end outstanding options price of year Outstanding at April 30, 2021 513,232 5.13 513,232 Options granted during 2022 464,500 6.26 Options exercised during 2022 ( 185,688 ) 5.02 Outstanding at April 30, 2022 792,044 5.79 549,669 Options cancelled during 2023 ( 11,650 ) 3.60 Options forfeited during 2023 ( 138,750 ) 6.66 Outstanding at April 30, 2023 641,644 $ 5.70 552,894 Intrinsic value is calculated as the positive difference between the market price of SigmaTron’s common stock and the exercise price of the underlying options. As of April 30, 2022, the aggregate intrinsic value of options exercised during 2022 was $465,487. As of April 30, 2023 and April 30, 2022, the aggregate intrinsic value of the options outstanding was none and $ 715,678 , respectively. As of April 30, 2023, the difference between the market price of the Company’s common stock and the exercise price of the underlying options was negative. Information with respect to stock options outstanding and exercisable at April 30, 2023 is as follows: Options outstanding and exercisable Number Weighted-average Weighted- outstanding at remaining average April 30, 2023 contract life exercise price Range of exercise prices $ 3.20 - 6.66 552,894 5.72 years $ 5.54 552,894 $ 5.54 As of April 30, 2023, there were 88,750 non-vested stock options.

Discontinued Operations

Discontinued Operations	12 Months Ended
	Apr. 30, 2023
Discontinued Operations [Abstract]
Discontinued Operations	NOTE P – DISCONTINUED OPERATIONS During the fourth quarter of fiscal 2023, the Company exited its active involvement in the Pet Tech business that is conducted by Wagz through the sale by the Company of a majority stake in Wagz, effective as of April 1, 2023. The Company entered into the SPA with Wagz, Buyer and Anderton, pursuant to which the Company sold to Buyer 81 % of the Shares for the purchase price of one dollar. Under the SPA, the Company also agreed to provide a Wagz Loan to Wagz during the month of April 2023. The Company agreed to work with Wagz as an EMS provider pursuant to a manufacturing agreement, but the Company did not commit to extending any further financial support beyond the Wagz Loan. On April 28, 2023, the sale of the majority interest in Wagz pursuant to the SPA was consummated with effect as of April 1, 2023, and as a result, as of the closing, the Company holds a minority 19 % ownership of the shares and Buyer holds a majority 81 % of the shares. In accordance with ASC 205-20 Presentation of Financial Statements: Discontinued Operations, a disposal of a component of an entity or a group of components of an entity is required to be reported as discontinued operations if the disposal represents a strategic shift that has (or will have) a major effect on an entity’s operations and financial results when the component of an entity meets the criteria in paragraph 205-20-45-10. In the period in which the component meets discontinued operations criteria the major current assets, other assets, current liabilities, and noncurrent liabilities shall be reported as components of total assets and liabilities separate from those balances of the continuing operations. At the same time, the results of all discontinued operations, less applicable income taxes (benefit), shall be reported as components of net income (loss) separate from the net income (loss) of continuing operations. Pet Tech Segment (Wagz Business) The following amounts related to the Pet Tech Segment (Wagz Business) have been segregated from the Company’s continuing operations and are reported as discontinued operations: Fiscal Year Ended April 30, 2023 2022 Net Sales $ 1,598,929 $ 549,929 Cost of products sold 1,732,352 509,327 Gross (loss) profit ( 133,423 ) 40,602 Selling and administrative expenses 9,656,999 2,920,277 Impairment of notes receivable and investment - 6,300,235 Impairment of goodwill and other long-lived assets 23,096,771 - Operating loss ( 32,887,193 ) ( 9,179,910 ) Loss on sale of a business ( 3,742,709 ) - Interest expense - 154 Loss before income taxes from discontinued operations ( 36,629,902 ) ( 9,180,064 ) Income tax benefit 1,860,093 678,313 Loss from discontinued operations $ ( 34,769,809 ) $ ( 8,501,751 ) NOTE P – DISCONTINUED OPERATIONS – Continued As noted above, the Company completed the sale of Wagz, effective as of April 1, 2023. The following amounts related to Wagz were classified as assets and liabilities of discontinued operations in the Consolidated Balance Sheet as of April 30, 2022: April 30, 2022 Cash and cash equivalents $ 556,054 Accounts receivable 81,508 Inventories, net 300,251 Prepaid expenses and other assets 62,068 Total current assets 999,881 Property, machinery and equipment, net 195,109 Intangible assets, net 10,759,315 Goodwill 13,320,534 Other assets 6,000 Total other long-term assets 24,280,958 TOTAL ASSETS $ 25,280,839 Trade accounts payable $ 85,780 Accrued expenses 419,820 Accrued wages 102,733 Total current liabilities 608,333 Deferred income taxes 215,000 Total long-term liabilities 215,000 TOTAL LIABILITIES $ 823,333

Selected Quarterly Financial Da

Selected Quarterly Financial Data From Continuing Operations	12 Months Ended
	Apr. 30, 2023
Selected Quarterly Financial Data From Continuing Operations [Abstract]
Selected Quarterly Financial Data From Continuing Operations	NOTE Q - SELECTED QUARTERLY FINANCIAL DATA FROM CONTINUING OPERATIONS (UNAUDITED) On April 1, 2023, SigmaTron completed the sale of its Wagz, Inc. business. The results of the Wagz, Inc. business have been reported as discontinued operations in the Consolidated Statements of Operations through the date of sale. These changes have been applied to all periods presented. See Note P — Discontinued Operations, for additional information. The following is a summary of unaudited quarterly financial data for fiscal year 2023: First Second Third Fourth 2023 Quarter Quarter Quarter Quarter Net sales $ 105,189,979 $ 108,221,068 $ 92,736,725 $ 108,288,074 Gross profit 11,577,220 13,306,079 11,160,904 15,409,394 Income before income 4,129,636 4,858,965 2,892,683 5,304,681 taxes (1) Net income from continuing operations 3,600,236 3,602,998 2,949,459 4,041,731 Earnings per share from continuing operations $ 0.59 $ 0.59 $ 0.49 $ 0.67 Basic Earnings per share $ 0.58 $ 0.59 $ 0.49 $ 0.67 Diluted Weighted average shares- Basic 6,058,908 6,071,288 6,071,288 6,077,490 Weighted average shares- Diluted 6,191,395 6,145,223 6,071,288 6,077,490 The Company records inventory reserves for valuation and shrinkage throughout the year based on historical data. In the fourth quarter of fiscal year 2023 physical inventory results were completed resulting in an increase in income before taxes of approximately $ 650,000 net of a provision for inventory reserves of approximately $ 1,900,000 . NOTE Q - SELECTED QUARTERLY FINANCIAL DATA FROM CONTINUING OPERATIONS (UNAUDITED) - Continued On April 1, 2023, SigmaTron completed the sale of its Wagz, Inc. business. The results of the Wagz, Inc. business have been reported as discontinued operations in the Consolidated Statements of Operations through the date of sale. These changes have been applied to all periods presented. See Note P — Discontinued Operations, for additional information. The following is a summary of unaudited quarterly financial data for fiscal year 2022: First Second Third Fourth 2022 Quarter Quarter Quarter Quarter Net sales $ 85,739,434 $ 100,216,614 $ 93,478,557 $ 98,881,890 Gross profit 9,582,478 11,777,586 12,409,967 10,621,238 Income (loss) before income 9,553,661 4,663,717 ( 1,216,112 ) 10,344,656 taxes (1) (2) Net income (loss) from continuing operations 8,796,716 3,150,205 ( 1,960,520 ) 8,379,518 Earnings (loss) per share from continuing operations $ 2.06 $ 0.72 $ ( 0.41 ) $ 1.39 Basic Earnings (loss) per share $ 2.02 $ 0.69 $ ( 0.41 ) $ 1.34 Diluted Weighted average shares- Basic 4,275,410 4,313,623 4,729,619 6,021,803 Weighted average shares- Diluted 4,353,912 4,553,899 4,729,619 6,246,580 1) The Company was notified of the forgiveness of the PPP Loan by the SBA on July 9, 2021 and all its principal and accrued interest were forgiven. The accounting for the forgiveness in the amount of $ 6,282,973 is reflected in the Company’s Statement of Operations as a non-cash gain upon extinguishment of long-term debt in the first quarter of fiscal 2022. 2) The Company records inventory reserves for valuation and shrinkage throughout the year based on historical data. In the fourth quarter of fiscal year 2022 physical inventory results were completed resulting in a decrease in income before taxes of approximately $ 411,000 . The Company did no t record a provision for inventory reserves in the fourth quarter of fiscal 2022.

Litigation

Litigation	12 Months Ended
	Apr. 30, 2023
Litigation [Abstract]
Litigation	NOTE R - LITIGATION From time to time the Company is involved in legal proceedings, claims, or investigations that are incidental to the Company’s business. In future periods, the Company could be subjected to cash cost or non-cash charges to earnings if any of these matters are resolved on unfavorable terms. However, although the ultimate outcome of any legal matter cannot be predicted with certainty, based on present information, including management’s assessment of the merits of any particular claim, the Company does not expect these legal proceedings or claims will have any material adverse impact on its future consolidated financial position or results of operations.

Summary Of Significant Accoun_2

Summary Of Significant Accounting Policies (Policy)	12 Months Ended
	Apr. 30, 2023
Significant Accounting Policies [Abstract]
Consolidation Policy	Consolidation Policy The consolidated financial statements include the accounts and transactions of SigmaTron International, Inc. (“SigmaTron”), its wholly-owned subsidiaries, Standard Components de Mexico, S.A., AbleMex S.A. de C.V., Digital Appliance Controls de Mexico, S.A. de C.V., Spitfire Controls (Vietnam) Co. Ltd., and Spitfire Controls (Cayman) Co. Ltd., SigmaTron International Trading Co., wholly-owned foreign enterprises Wujiang SigmaTron Electronics Co. Ltd., and Wujiang SigmaTron Electronic Technology Co., Ltd. (collectively, “SigmaTron China”), its international procurement office, SigmaTron International Inc. Taiwan Branch, and Wagz, Inc. (majority of business sold, effective as of April 1, 2023). The functional currency of the Mexican, Vietnamese and Chinese subsidiaries and procurement branch is the U.S. Dollar. Intercompany transactions are eliminated in the consolidated financial statements. The impact of currency fluctuations for the fiscal year ended April 30, 2023, resulted in net foreign currency transaction losses of $ 892,642 compared to net foreign currency losses of $ 412,218 in the prior year.
Discontinued Operations	Discontinued Operations On April 1, 2023, SigmaTron completed the sale of its Wagz, Inc. business. In accordance with the authoritative guidance for discontinued operations (Accounting Standards Codification (ASC) 205-20), the Company determined that the Wagz, Inc. business met discontinued operations accounting criteria at the end of the fourth quarter of fiscal year 2023. The results of the Wagz, Inc. business and the related cash flows have been reported as discontinued operations in the Consolidated Statements of Operations and Consolidated Statements of Cash Flows, respectively, through the date of sale. These changes have been applied to all periods presented. See Note P — Discontinued Operations, for additional information.
Use Of Estimates	Use of Estimates The preparation of consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”) requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Significant estimates made in preparing the consolidated financial statements include depreciation and amortization periods, the allowance for doubtful accounts, excess and obsolete reserves for inventory, deferred income, deferred taxes, valuation allowance for deferred taxes and valuation of goodwill and long-lived assets. Actual results could materially differ from these estimates.
Cash And Cash Equivalents	Cash and Cash Equivalents Cash and cash equivalents include cash and all highly liquid short-term investments with original maturities within three months of the purchase date.
Accounts Receivable	Accounts Receivable The majority of the Company’s accounts receivable are due from companies in the industrial electronics, consumer electronics and medical/life sciences industries. Credit is extended based on evaluation of a customer’s financial condition, and, generally, collateral is not required. Accounts receivable are due in accordance with agreed upon terms, and are stated at amounts due from customers net of an allowance for doubtful accounts. Accounts outstanding longer than the contractual payments terms are considered past due. The Company writes off accounts receivable when they are determined to be uncollectible.
Financing Receivables	Financing Receivables The Company has arrangements with various financial institutions to sell certain eligible accounts receivable balances from specific customers without recourse. The accounts receivable balances sold are at the election of the Company. The Company incurred fees for such sales, which are reflected as selling and administrative expenses on the Company’s Consolidated Statements of Operations and were not material for the fiscal years ended April 30, 2023 and 2022. The accounts receivable balances are derecognized at the time of sale, as the Company does not have continuing involvement after the point of sale. During the years ended April 30, 2023 and April 30, 2022, the Company sold without recourse trade receivables of approximately $ 94,000,000 and $ 121,000,000 , respectively. Cash proceeds from these agreements are reflected as operating activities included in the change in accounts receivable in the Company's Consolidated Statements of Cash Flows.
Allowance For Doubtful Accounts	Allowance for Doubtful Accounts The Company’s allowance for doubtful accounts relates to receivables not expected to be collected from its customers. This allowance is based on management’s assessment of specific customer balances, considering the age of receivables and financial stability of the customer and a five-year average of prior uncollectible amounts. If there is an adverse change in the financial condition of the Company’s customers, or if actual defaults are higher than provided for, an addition to the allowance may be necessary.
Inventories	Inventories Inventories are valued at cost. Cost is determined by an average cost method and the Company allocates labor and overhead to work-in-process and finished goods. In the event of an inventory write-down, the Company records expense to state the inventory at lower of cost or net realizable value. The Company establishes inventory reserves for shrinkage and excess and obsolete inventory. The Company records provisions for inventory shrinkage based on historical experience to account for unmeasured usage or loss. Of the Company’s raw materials inventory, a substantial portion has been purchased to fulfill committed future orders or for which the Company is contractually entitled to recover its costs from its customers. For the remaining raw materials inventory, a provision for excess and obsolete inventories is recorded for the difference between the cost of inventory and its estimated realizable value based on assumptions about future product demand and market conditions. Upon a subsequent sale or disposal of the impaired inventory, the corresponding reserve is relieved to ensure the cost basis of the inventory reflects any reductions. Actual results differing from these estimates could significantly affect the Company’s inventories and cost of products sold as the inventory is sold or otherwise relieved.
Property, Machinery And Equipment	Property, Machinery and Equipment Property, machinery and equipment are valued at cost. The Company provides for depreciation and amortization using the straight-line method over the estimated useful life of the assets: Buildings 20 years Machinery and equipment 5 - 12 years Office equipment and software 3 - 5 years Tools and dies 12 months Leasehold improvements lesser of lease term or useful life Expenses for repairs and maintenance are charged to selling and administrative expenses as incurred.
Deferred Financing Costs	Deferred Financing Costs Deferred financing costs consist of costs incurred to obtain the Company’s long-term debt and are amortized using the straight line method, which approximates the effective interest method, over the term of the related debt. Deferred financing fees of $ 1,608,558 and $ 401,040 net of accumulated amortization of $ 457,992 and $ 99,477 , respectively, as of April 30, 2023 and 2022, respectively, are deducted from long term debt on the Company’s Consolidated Balance Sheet.
Risks and Uncertainties	Risks and Uncertainties Since 2020, the global COVID-19 pandemic has created significant business disruption and economic uncertainty which adversely impacted our manufacturing operations, supply chain, and distribution channels. While the immediate impacts of the COVID-19 pandemic have been assessed, the long-term effects of the disruption, including supply chain disruption, and resulting impact on the global economy and capital markets remain unpredictable, and depend on future developments such as the potential resurgence of the crisis, variant strains of the virus, vaccine availability and effectiveness, and future government actions in response to the crisis. This unpredictability could limit our ability to respond to future developments quickly.
Income Taxes	Income Taxes The Company’s income tax expense, deferred tax assets and liabilities and reserves for unrecognized tax benefits reflect management’s best assessment of estimated future taxes to be paid. The Company is subject to income taxes in both the U.S. and several foreign jurisdictions. Significant judgments and estimates by management are required in determining the consolidated income tax expense assessment. Deferred income tax assets and liabilities are determined based on differences between financial reporting and tax basis of assets and liabilities, and are measured using the enacted tax rates and laws that are expected to be in effect when the differences are expected to reverse. In evaluating the Company’s ability to recover its deferred tax assets within the jurisdiction from which they arise, the Company considers all available positive and negative evidence, including scheduled reversals of deferred tax liabilities, projected future taxable income, tax planning strategies and recent financial operations. In projecting future taxable income, the Company begins with historical results and changes in accounting policies, and incorporates assumptions including the amount of future state, federal and foreign pre-tax operating income, the reversal of temporary differences, and the implementation of feasible and prudent tax planning strategies. These assumptions require significant judgment and estimates by management about the forecasts of future taxable income and are consistent with the plans and estimates the Company uses to manage the underlying businesses. In evaluating the objective evidence that historical results provide, the Company considers three years of cumulative operating income and/or loss. Valuation allowances are established when necessary to reduce deferred income tax assets to an amount more likely than not to be realized. A tax benefit from an uncertain tax position may only be recognized when it is more likely than not that the position will be sustained upon examination, including resolutions of any related appeals or litigation processes, based on the technical merits. The calculation of the Company’s tax liabilities involves dealing with uncertainties in the application of complex tax laws and regulations in a multitude of jurisdictions across its global operations. Changes in tax laws and rates could also affect recorded deferred tax assets and liabilities in the future. Except as noted below, management is not aware of any such changes that would have a material effect on the Company’s results of operations, cash flows or financial position. The Company adjusts its tax liabilities when its judgment changes as a result of the evaluation of new information not previously available. Due to the complexity of some of these uncertainties, the ultimate resolution may result in a payment that is materially different from its current estimate of the tax liabilities. These differences will be reflected as increases or decreases to income tax expense in the period in which they are determined.
Earnings Per Share	Earnings per Share Basic earnings per share are computed by dividing net income (loss) (the numerator) by the weighted-average number of common shares outstanding (the denominator) for the period. The computation of diluted earnings per share is similar to the computation of basic earnings per share, except that the denominator is increased to include the number of additional common shares that would have been outstanding if the potentially dilutive common stock equivalents such as stock options and restricted stock, had been exercised or vested. There were 105,286 anti-dilutive common stock equivalents and no anti-dilutive common stock equivalents at April 30, 2023 and April 30, 2022, respectively, which have been excluded from the calculation of diluted earnings per share. Fiscal Years Ended April 30, 2023 2022 Net income from continuing operations $ 14,194,424 $ 18,365,919 Net loss from discontinued operations ( 34,769,809 ) ( 8,501,751 ) Total net (loss) income ( 20,575,385 ) 9,864,168 Weighted-average shares Basic 6,069,680 4,825,360 Effect of dilutive stock options - 303,874 Diluted 6,069,680 5,129,234 Basic (loss) earnings per common share Basic earnings per share from continuing operations 2.34 3.81 Basic loss per share from discontinued operations ( 5.73 ) ( 1.77 ) Basic total (loss) earnings per share $ ( 3.39 ) $ 2.04 Diluted (loss) earnings per common share Diluted earnings per share from continuing operations 2.34 3.58 Diluted loss per share from discontinued operations ( 5.73 ) ( 1.66 ) Diluted total (loss) earnings per share $ ( 3.39 ) $ 1.92
Revenue Recognition	Revenue Recognition The Company recognizes revenue when control of the promised goods or services are transferred to its customers, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. The Company’s primary performance obligation to its customers is the production of finished goods electronic assembly products pursuant to purchase orders. The Company has concluded that control of the products it sells and transfers to its customers and an enforceable right to receive payment is customarily established at the point in time when the finished goods are shipped to its customers, or in some cases delivered pursuant to the specified shipping terms of each customer arrangement. With respect to consignment arrangements, control transfers and revenue is recognized at the point in time when the goods are shipped to the customer from the consignment location or when delivered to the customer (pursuant to agreed upon shipping terms). In those limited instances where finished goods delivered to the customer location are stored in a segregated area which are not controlled by the customer (title transfer) until they are pulled from the segregated area and consumed by the Company’s customer, revenue is recognized upon consumption. For tooling services, the Company’s performance obligation is satisfied at the point in time when the customer takes legal possession of dies or molds, which accounted for less than 1% of the Company’s NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Revenue Recognition - Continued revenue. For engineering, design, and testing services, the Company’s performance obligations are satisfied over time as the respective services are rendered as its customers simultaneously derive value from the Company’s performance. From the time that a customer purchase order is received and contract is established, the Company’s performance obligations are typically fulfilled within a few weeks after receipt of all material. The Company does not have any performance obligations that require more than 12 months to fulfill. Each customer purchase order sets forth the transaction price for the products and services purchased under that arrangement. The Company evaluates the credit worthiness of its customers and exercises judgment to recognize revenue based upon the amount the Company expects to be paid for each sales transaction it enters into with its customers. Some customer arrangements include variable consideration, such as volume rebates, some of which depend upon the Company’s customers meeting specified performance criteria, such as a purchasing level over a period of time. The Company exercises judgment to estimate the most likely amount of variable consideration at each reporting date. The Company’s typical payment terms are 30 days and its sales arrangements do not contain any significant financing component for its customers. The Company’s customer arrangements do not generate contract assets that are material to the consolidated financial statements. Contract liabilities consist of payments received in advance of the transfer of control to the customer. As products are delivered and control transfers, the Company recognizes the deferred revenue in net sales in the Consolidated Statements of Operations. The following table summarizes the deferred revenue associated with payments received in advance of the transfer of control to the customer reported as deferred revenue in the Consolidated Balance Sheets and amounts recognized through net sales for each period presented. Fiscal Years Ended April 30, 2023 2022 Contract Liability (deferred revenue) $ 8,063,197 $ 11,394,820 Revenue recognized in the period from amounts included in the contact liability at the beginning of the period $ 11,394,820 $ 423,971 The Company generally provides a warranty for workmanship, unless the assembly was designed by the Company, in which case it warrants assembly/design. The Company assembles and tests assemblies based on customers’ specifications prior to shipment. Historically, the amount of returns for workmanship issues has been de minimis under the Company’s standard or extended warranties. The Company does not provide its customers the option to purchase additional warranties and, therefore, the Company’s warranties are not considered a separate service or performance obligation. The Company utilizes the practical expedient to treat shipping and handling activities after the customer obtains control as fulfillment activities. The Company records shipping and handling costs as selling and administrative expenses and costs are accrued when revenue is recognized. The Company pays sales commissions to its sales representatives which may be considered as incremental costs to obtain a contract. However, since the recoverability period is less than one year, the Company utilizes the practical expedient provided by the revenue recognition accounting standard that allows an entity to expense the costs of obtaining a contract as incurred. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Revenue Recognition - Continued During fiscal year 2023, no revenues were recognized from performance obligations satisfied or partially satisfied in previous periods and no amounts were allocated to performance obligations that remain unsatisfied or partially unsatisfied at April 30, 2023. The Company is electing not to disclose the value of the remaining unsatisfied performance obligation with a duration of one year or less as permitted by the practical expedient in ASU 2014-09, “ Revenue from Contracts with Customers.” The Company had no material remaining unsatisfied performance obligations as of April 30, 2023, with an expected duration of greater than one year. The majority of sales are made to U.S. based customers. The following table presents the Company’s revenue disaggregated by the principal end-user markets it serves: Year Ended April 30, Year Ended April 30, Net sales by end-market 2023 2022 Industrial Electronics $ 278,844,264 $ 209,405,083 Consumer Electronics 109,043,652 145,972,308 Medical / Life Sciences 26,547,929 22,939,104 Total Net Sales $ 414,435,845 $ 378,316,495
Shipping And Handling Costs	Shipping and Handling Costs The Company records shipping and handling costs for goods shipped to customers as selling and administrative expenses. Customers are typically invoiced for shipping costs and such amounts are included in net sales. Shipping and handling costs were not material to the financial statements for fiscal years 2023 or 2022.
Fair Value Measurements	Fair Value Measurements Fair value measurements are determined based upon the exit price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants exclusive of any transaction costs. The Company utilizes a fair value hierarchy based upon the observability of inputs used in valuation techniques as follows: Level 1: Observable inputs such as quoted prices in active markets; Level 2: Inputs, other than quoted prices in active markets, that are observable either directly or indirectly; and Level 3: Unobservable inputs in which there is little or no market data, which require the reporting entity to develop its own assumptions.
Fair Value Of Financial Instruments	Fair Value of Financial Instruments The Company’s financial instruments include cash and cash equivalents, accounts receivable, note receivable, other receivables, accounts payable and accrued expenses which approximate fair value at April 30, 2023 and April 30, 2022, due to their short-term nature and are considered Level 1. The carrying amounts of the Company’s debt obligations approximate fair value based on future payments discounted at current interest rates for similar obligations or interest rates which fluctuate with the market and are considered Level 2.
Intangible Assets	Intangible Assets Intangible assets are comprised of finite life intangible assets including customer relationships, trade names and patents. Finite life intangible assets are amortized on a straight line basis over their estimated useful lives of 20 years for trade names, 18 years for patents, and customer relationships which are amortized on an accelerated basis over their estimated useful life of 15 years.
Impairment Of Long-Lived Assets	Impairment of Long-Lived Assets The Company reviews long-lived assets, including amortizable intangible assets, for impairment in accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) 360: Property, Plant and Equipment . Property, machinery and equipment and finite life intangible assets are reviewed whenever events or changes in circumstances occur that indicate possible impairment. If events or changes in circumstances occur that indicate possible impairment, the Company first performs an impairment review based on an undiscounted cash flow analysis at the lowest level at which cash flows of the long-lived assets are largely independent of other groups of its assets and liabilities. This analysis requires management judgment with respect to changes in technology, the continued success of product lines, and future volume, revenue and expense growth rates. If the carrying value exceeds the undiscounted cash flows, the Company records an impairment, if any, for the difference between the estimated fair value of the asset group and its carrying value. The Company further conducts annual reviews of its long-lived asset groups for possible impairment. During the third quarter of fiscal 2023, the Company revised the financial outlook for the Pet Tech segment, resulting in lower projected sales and net income for future periods. The Company assessed the overall market acceptance of the current Wagz product offerings after the holiday season and determined that this constituted a triggering event for the Company’s long-lived asset groups, primarily consisting of patents, trade names and certain fixed assets. The Company reviewed the undiscounted future cash flows for the identified long-lived asset group, and the results of the analysis indicated the carrying amount for the long-lived group was not expected to be recovered. The fair value of the identified intangible assets was estimated using the relief from royalty method, which is a risk-adjusted discounted cash flow approach. The relief from royalty method values an intangible asset by estimating the royalties saved through ownership of the asset. The relief from royalty method requires identifying the future revenue that would be generated by the intangible asset, multiplying it by a royalty rate deemed to be avoided through ownership of the asset and discounting the projected royalty savings amounts back to the acquisition date using the internal rate of return. The Company determined the fair value of the long-lived asset group was lower than its carrying value and recorded an intangible asset impairment charge of $ 9,527,773 during the third quarter of fiscal 2023. This non-cash charge was recorded to impairment of goodwill and intangible assets on the unaudited condensed consolidated statements of operations as of January 31, 2023. As of April 30, 2023 this non-cash charge has been reported under discontinued operations. See Note H – Intangible Assets and Note P – Discontinued Operations, for more information. The Company’s analysis for 2023 did not indicate that any of its other long-lived assets were impaired. The Company has yet to experience significant cancellations of orders; however, the potential impact of future disruptions, may have a significant adverse impact on the timing of delivery of customer orders and the levels of future customer orders.
Goodwill	Goodwill Goodwill represents the excess cost over fair value of the net assets of acquired businesses. The Company does not amortize goodwill and intangible assets that have indefinite lives. The Company performs an impairment assessment of goodwill and intangible assets with indefinite lives annually, or more frequently if triggering events occur, based on the estimated fair value of the related reporting unit or intangible asset. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants. When performing its annual impairment assessment as of April 30, the Company evaluates the goodwill assigned to each of its reporting units for potential impairment by comparing the estimated fair value of the relevant reporting unit to the carrying value. The Company uses various Level 2 and Level 3 valuation techniques to determine the fair value of its reporting units, including discounting estimated future cash flows based on a cash flow forecast prepared by the relevant reporting unit and market multiples of relevant public companies. If the fair value of a reporting unit is less than its carrying value, a goodwill impairment loss is recorded for the difference. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued Goodwill - Continued The Company observed during the third quarter of fiscal 2023, the overall lack of market acceptance of the current Wagz product offerings during the holiday season and determined this constituted a triggering event. Accordingly, the Company performed a quantitative goodwill impairment test and estimated the fair value of the Pet Tech segment based on a combination of an income approach (estimates of future discounted cash flows), a market approach (market multiples for similar companies) and a cost approach. Significant unobservable inputs and assumptions inherent in the valuation methodologies, which represented Level 3 inputs, under the fair value hierarchy, were employed and included, but were not limited to, prospective financial information, terminal value assumptions, discount rates, and multiples from comparable publicly traded companies in the Pet Tech industry. The cost approach is based on upon the concept of replacement cost as an indicator of value. Stated another way, this approach is premised on the assumption that a prudent investor would pay no more for an asset than the amount for which the asset could be replaced. The cost approach establishes value based on the cost reproducing or replacing the property, less depreciation from physical deterioration and functional obsolescence, if present and measurable. During the third quarter of fiscal 2023, the Company determined its goodwill was fully impaired as the fair value was lower than the carrying value and recorded an impairment charge of $ 13,320,534 . This non-cash charge was recorded to impairment of goodwill and intangible assets on the unaudited condensed consolidated statements of operations. As of April 30, 2023 this non-cash charge has been reported under discontinued operations. See Note P – Discontinued Operations, for more information.
Investment In Wagz	Investment in Wagz On December 31, 2021, the Company acquired 100 % of the stock of Wagz under the terms of the Agreement and Plan of Merger dated July 19, 2021, as amended by the First Amendment to Agreement and Plan of Merger dated December 7, 2021 (the “Merger Agreement”) . Wagz has developed and brought to market a high tech pet collar and has multiple other products in development. Wagz is an internet of things (“IoT”) company which both owns intellectual property and secures recurring revenue through subscriptions for its services. Prior to the acquisition, the Company had an investment in Wagz of $ 600,000 , Convertible Secured Promissory Notes issued by Wagz of $ 12,000,000 and Secured Promissory Notes issued by Wagz of $ 1,380,705 . Pursuant to the Merger Agreement, prior to the acquisition, the Convertible Secured Promissory Notes converted to 12,000,000 shares of Wagz common stock, resulting in a 25.5 % ownership in Wagz. The Company's 25.5 % equity interest in Wagz common stock was remeasured to fair value of $ 6,299,765 , resulting in a non-cash impairment charge of $ 6,300,235 within the Statements of Operations during fiscal year 2022. Pursuant to the Merger Agreement, 2,443,870 shares of common stock of the Company were issued in the merger for a value of 25,245,177 , of which 1,546,592 shares are allocated to Wagz shareholders (excluding the Company) for a total value of $ 15,976,295 , and 897,278 shares are allocated to the Company and treated as treasury stock for a total value of $ 9,268,881 , recorded in the Statements of Changes in Stockholders’ Equity for the fiscal year 2022. The treasury shares were retired as of April 30, 2022. On April 28, 2023, effective as of April 1, 2023, the Company sold a majority of its interest in Wagz, which operated the Pet Tech business. Please refer to Note F – Acquisition, for more information. NOTE B - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Continued
Stock Incentive Plans	Stock Incentive Plans Under the Company’s stock option plans, options to acquire shares of SigmaTron’s common stock have been made available for grant to certain employees. Each option granted has an exercise price of not less than 100 % of the market value of the common stock on the date of grant. The contractual life of each option is generally 10 years. The vesting of the grants varies according to the individual options granted. The Company measures the cost of employee services received in exchange for an equity award based on the grant date fair value and records that cost over the respective vesting period of the award. The Company has a restricted stock plan under which non-employee directors may acquire shares of SigmaTron’s common stock. The restricted stock plan has been approved by the Company’s stockholders. The restricted stock plan is interpreted and administered by the Compensation Committee of SigmaTron’s Board of Directors. All awarded stock under the plan vests in six months from the date of grant. Awarded stock under this plan is granted at the closing price of SigmaTron’s common stock on the date of grant.
New Accounting Standards	New Accounting Standards In June 2016, the FASB issued ASU No. 2016-13, “ Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments .” ASU 2016-13, as amended by ASU 2019-04 and ASU 2019-05, that introduces a new forward-looking approach, based on expected losses, to estimate credit losses on certain types of financial instruments, including trade receivables. The estimate of expected credit losses will require entities to incorporate considerations of historical information, current information and reasonable and supportable forecasts. This ASU also expands the disclosure requirements to enable users of financial statements to understand the entity’s assumptions, models and methods for estimating expected credit losses. For smaller reporting companies, ASU 2016- 13 is effective for annual and interim reporting periods beginning after December 15, 2022, and the guidance is to be applied using the modified-retrospective approach. Earlier adoption is permitted. The Company is currently evaluating the impact of this guidance on its consolidated financial statements but is not expected to have a material impact on the consolidated financial statements. In March 2020, the FASB issued ASU 2020-04, “ Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting ”, which provides optional expedients and exceptions for a period of time to ease the potential burden in accounting for the transition from reference rates that are expected to be discontinued. Regulators and market participants in various jurisdictions have undertaken efforts to eliminate certain reference rates and introduce new reference rates that are based on a larger and more liquid population of observable transactions. The amendments in this update apply only to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. The expedients and exceptions provided by the amendments do not apply to contract modifications made and hedging relationships entered into or evaluated after December 31, 2022, except for hedging relationships existing as of December 31, 2022, that an entity has elected certain optional expedients for and that are retained through the end of the hedging relationship. In January 2021, the FASB issued clarification on the scope of relief related to the reference rate reform. In December 2022, the FASB extended the period of time entities can use the reference rate reform relief guidance by two years which defers the sunset date from December 31, 2022 to December 31, 2024. The Company adopted this ASU in fiscal 2023 and it had no impact on its consolidated financial statements.

Summary Of Significant Accoun_3

Summary Of Significant Accounting Policies (Tables)	12 Months Ended
	Apr. 30, 2023
Significant Accounting Policies [Abstract]
Depreciation and Amortization Using Straight-Line Method Over Estimated Useful Life	Buildings 20 years Machinery and equipment 5 - 12 years Office equipment and software 3 - 5 years Tools and dies 12 months Leasehold improvements lesser of lease term or useful life
Computation Of Basic And Diluted Earnings Per Share	Fiscal Years Ended April 30, 2023 2022 Net income from continuing operations $ 14,194,424 $ 18,365,919 Net loss from discontinued operations ( 34,769,809 ) ( 8,501,751 ) Total net (loss) income ( 20,575,385 ) 9,864,168 Weighted-average shares Basic 6,069,680 4,825,360 Effect of dilutive stock options - 303,874 Diluted 6,069,680 5,129,234 Basic (loss) earnings per common share Basic earnings per share from continuing operations 2.34 3.81 Basic loss per share from discontinued operations ( 5.73 ) ( 1.77 ) Basic total (loss) earnings per share $ ( 3.39 ) $ 2.04 Diluted (loss) earnings per common share Diluted earnings per share from continuing operations 2.34 3.58 Diluted loss per share from discontinued operations ( 5.73 ) ( 1.66 ) Diluted total (loss) earnings per share $ ( 3.39 ) $ 1.92
Revenue Disaggregated By Principal End-User Markets	Year Ended April 30, Year Ended April 30, Net sales by end-market 2023 2022 Industrial Electronics $ 278,844,264 $ 209,405,083 Consumer Electronics 109,043,652 145,972,308 Medical / Life Sciences 26,547,929 22,939,104 Total Net Sales $ 414,435,845 $ 378,316,495

Allowance for Doubtful Accoun_2

Allowance for Doubtful Accounts (Tables)	12 Months Ended
	Apr. 30, 2023
Allowance For Doubtful Accounts [Abstract]
Changes In Company's Allowance For Doubtful Accounts	2023 2022 Beginning Balance $ 100,000 $ 100,000 Bad debt expense - - Bad debt recovery - - Write-offs - - $ 100,000 $ 100,000

Inventories (Tables)

Inventories (Tables)	12 Months Ended
	Apr. 30, 2023
Inventories [Abstract]
Components Of Inventory	2023 2022 Finished products $ 22,093,018 $ 21,875,390 Work-in-process 5,415,917 5,907,766 Raw materials 142,612,325 140,118,156 170,121,260 167,901,312 Less obsolescence reserve 4,566,061 3,236,347 $ 165,555,199 $ 164,664,965
Changes In Inventory Obsolescence Reserve	2023 2022 Beginning balance $ 3,236,347 $ 2,414,310 Provision for obsolescence 488,000 1,711,599 Provision for Wagz inventory 1,441,063 - Write-offs ( 599,349 ) ( 889,562 ) $ 4,566,061 $ 3,236,347

Property, Machinery And Equip_2

Property, Machinery And Equipment, Net (Tables)	12 Months Ended
	Apr. 30, 2023
Property, Machinery And Equipment, Net [Abstract]
Schedule Of Property, Machinery And Equipment	2023 2022 Land and buildings $ 18,826,246 $ 18,653,248 Machinery and equipment 85,895,593 81,551,714 Office equipment and software 14,675,432 13,738,965 Leasehold improvements 3,137,540 3,016,857 Equipment under finance leases 6,300,225 6,642,719 128,835,036 123,603,503 Less accumulated depreciation and amortization, including accumulated amortization of assets under finance leases of $ 1,006,128 and $ 1,081,476 at April 30, 2023 and 2022, respectively 93,046,679 87,825,397 Property, machinery and equipment, net $ 35,788,357 $ 35,778,106

Acquisition (Tables)

Acquisition (Tables)	12 Months Ended
	Apr. 30, 2023
Acquisition And Disposition [Abstract]
Consideration For Acquisition	Consideration Issuance of 1,546,592 common stock of SigmaTron $ 15,976,295 Fair value of consideration transferred 15,976,295 Secured Promissory Notes 1,380,173 Fair value of SigmaTron's equity interest in Wagz held prior to the business combination (Note B) 6,299,765 $ 23,656,233
Preliminary Allocation Of Purchase Consideration	Cash $ 508,274 Working capital 224,046 Property, plant and equipment 201,839 Acquired intangible assets 10,960,000 Right-of-use operating lease assets 647,076 Other assets 6,000 Operating lease obligations ( 647,077 ) Deferred tax liability ( 215,000 ) Other liabilities ( 1,349,459 ) Goodwill 13,320,534 Fair value of purchase consideration $ 23,656,233
Intangible Assets Acquired	Expected Weighted Amortization Fair Value Period Trade name $ 1,230,000 20 years Patents 9,730,000 18 years $ 10,960,000

Segment and Geographic Area I_2

Segment and Geographic Area Information (Tables)	12 Months Ended
	Apr. 30, 2023
Segment And Geographic Area Information [Abstract]
Schedule of Segment Reporting Information	Fiscal Year Ended April 30, 2023 EMS Pet Tech Segment Segment Consolidated Net sales (1) (2) $ 414,435,845 $ 1,598,929 $ 416,034,774 Operating income (loss) (2) 24,957,646 ( 32,887,193 ) ( 7,929,547 ) Other income 632,223 Interest expense, net ( 8,403,904 ) Loss before income taxes $ ( 15,701,228 ) Purchases of machinery and equipment 4,334,169 134,419 4,468,588 Depreciation and amortization 5,817,659 45,877 5,863,536 Identifiable assets $ 268,627,199 $ $ 268,627,199 (1) The EMS segment manufactures products sold to the Pet Tech segment. Related intersegment sales of $ 938,370 have been eliminated. (2) The results for the Pet Tech Segment are reported as discontinued operations for fiscal 2023 and fiscal 2022. Fiscal Year Ended April 30, 2022 EMS Pet Tech Segment Segment Consolidated Net sales (1) (2) $ 378,316,495 $ 549,929 $ 378,866,424 Operating income (loss) (2) 18,409,475 ( 9,180,064 ) 9,229,411 Gain on extinguishment of long-term debt 6,282,973 Other income 153,614 Interest expense, net ( 1,500,140 ) Income before income taxes $ 14,165,858 Purchases of machinery and equipment 4,740,100 9,432 4,749,532 Depreciation and amortization 5,720,157 16,161 5,736,318 Identifiable assets (2) $ 268,350,438 $ 25,280,839 $ 293,631,277 (1) The EMS segment manufactures products sold to the Pet Tech segment. Related intersegment sales of $ 213,298 have been eliminated. (2) The results for the Pet Tech Segment are reported as discontinued operations for fiscal 2023 and fiscal 2022.
Schedule of Net Sales and Tangible Long-lived Assets by Geographical Areas	Fiscal Year Ended April 30, 2023 April 30, 2022 Net sales: U.S. $ 117,389,877 $ 89,119,720 China 48,584,165 46,347,260 Vietnam 11,523,284 13,981,553 Mexico 236,938,519 228,867,962 Total net sales $ 414,435,845 $ 378,316,495 Fiscal Year Ended April 30, 2023 April 30, 2022 Tangible long-lived assets, net: U.S. $ 20,371,298 $ 21,538,417 China 4,212,780 5,060,021 Mexico 17,574,899 18,839,855 Other 854,803 1,286,577 Total tangible long-lived assets, net $ 43,013,780 $ 46,724,870

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Apr. 30, 2023
Intangible Assets [Abstract]
Summary Of Intangible Assets Subject To Amortization	April 30, 2023 Gross Carrying Accumulated Impairment Write Off Net Intangible Amount Amortization Amount Amount Asset Balance Spitfire: Non-contractual customer relationship 4,690,000 3,378,970 - - 1,311,030 Wagz: Trade name 1,230,000 68,380 813,960 347,660 - Patents 9,730,000 586,313 8,713,813 429,874 - Total $ 15,650,000 $ 4,033,663 $ 9,527,773 $ 777,534 $ 1,311,030 Intangible assets subject to amortization are summarized as of April 30, 2022, as follows: April 30, 2022 Gross Carrying Accumulated Net Intangible Amount Amortization Asset Balance Spitfire: Non-contractual customer relationship 4,690,000 3,039,837 1,650,163 Wagz: Trade name 1,230,000 20,500 1,209,500 Patents 9,730,000 180,185 9,549,815 Less intangible assets of discontinued operations 10,960,000 200,685 10,759,315 $ 4,690,000 $ 3,039,837 $ 1,650,163
Estimated Aggregate Amortization Expense	For the fiscal years ending April 30: 2024 $ 331,842 2025 324,702 2026 317,728 2027 310,900 2028 25,858 $ 1,311,030

Long-Term Debt (Tables)

Long-Term Debt (Tables)	12 Months Ended
	Apr. 30, 2023
Long-Term Debt [Abstract]
Schedule Of Debt And Finance Lease Obligations	2023 2022 Debt: Notes Payable - Banks $ 90,968,000 $ 56,830,377 Notes Payable - Buildings 417,143 6,459,340 Notes Payable - Equipment 3,524,115 4,202,292 Unamortized deferred financing costs ( 1,608,558 ) ( 401,040 ) Total debt 93,300,700 67,090,969 Less current maturities* 52,761,520 6,991,567 Long-term debt $ 40,539,180 $ 60,099,402 Finance lease obligations $ 4,119,437 $ 4,215,810 Less current maturities 1,523,259 1,410,675 Total finance lease obligations, less current portion $ 2,596,178 $ 2,805,135 * Due to availability being less than 10 % of the Revolving Commitment, the Facility (as defined below) has been classified as a current liability on the Consolidated Balance Sheet as of April 30, 2023.
Schedule Of Debt To EBITDA Ratio	Fiscal Quarter Total Debt to EBITDA Ratio* (as amended) Total Debt to EBITDA Ratio* (prior to amendment) October 31,2023 4.50 :1.0 4.25 :1.0 January 31, 2024 4.50 :1.0 4.00 :1.0 April 30, 2024 4.50 :1.0 4.00 :1.0 July 31, 2024 4.25 :1.0 3.75 :1.0 October 31, 2024 4.00 :1.0 3.75 :1.0 * Assumes the T erm Loan Borrowing Base Coverage Ratio (as defined in the Credit Agreements) is less than or equal to 1.50:1.0.
Aggregate Amount Of Debt, Net Deferred Financing Fees	Fiscal Year Bank Building Equipment Total 2024 $ 51,562,508 $ 50,571 $ 1,148,441 $ 52,761,520 2025 1,501,272 53,557 1,176,986 2,731,815 2026 1,751,272 56,719 841,614 2,649,605 2027 1,751,272 60,068 291,085 2,102,425 2028 32,793,118 63,614 65,989 32,922,721 Thereafter - 132,614 - 132,614 $ 89,359,442 $ 417,143 $ 3,524,115 $ 93,300,700 * Due to availability being less than 10% of the Revolving Commitment, the Facility (as defined above) has been classified as a current liability on the Consolidated Balance Sheet as of April 30, 2023. The maturity date of both the Facility and the TCW Term Loan is July 18, 2027 with an outstanding balance of $ 89,359,442 .
Schedule of Finance Lease Obligations	Fiscal Year Total 2024 $ 1,856,501 2025 1,674,988 2026 1,007,719 2027 177,772 2028 - Total minimum lease payments 4,716,980 Less: Amounts representing interest 597,543 Present value of net minimum lease payments $ 4,119,437

Accrued Expenses and Wages (Tab

Accrued Expenses and Wages (Tables)	12 Months Ended
	Apr. 30, 2023
Accrued Expenses And Wages [Abstract]
Schedule Of Accrued Expenses	2023 2022 Interest $ 505,423 $ 156,776 Commissions 193,480 141,008 Professional fees 268,526 475,761 Other - Purchases 359,647 852,862 Other 1,606,354 1,126,695 $ 2,933,430 $ 2,753,102
Schedule Of Accrued Wages	2023 2022 Domestic wages $ 2,184,469 $ 2,597,312 Bonuses 2,282,927 3,624,794 Foreign wages 3,449,870 2,855,743 $ 7,917,266 $ 9,077,849

Income Tax (Tables)

Income Tax (Tables)	12 Months Ended
	Apr. 30, 2023
Income Tax [Abstract]
Income Before Income (Loss) Tax Expense (Benefit)	2023 2022 Domestic $ 11,138,944 $ 19,155,489 Foreign 6,047,021 4,190,433 $ 17,185,965 $ 23,345,922
Income Tax Expense	2023 2022 Current Federal $ 3,219,203 $ 2,255,406 State 742,275 560,436 Foreign 1,392,834 1,010,149 Total Current 5,354,312 3,825,991 Deferred Federal ( 2,282,300 ) 1,315,037 State ( 459,788 ) 326,217 Foreign 379,317 ( 487,242 ) Total Deferred ( 2,362,771 ) 1,154,012 Income tax $ 2,991,541 $ 4,980,003
Reconciliation Of Income Taxes	2023 2022 U.S Federal Provision: At statutory rate $ 3,609,047 $ 4,902,642 State taxes ( 1,007,854 ) 521,668 Change in valuation allowance 5,909,955 1,179,616 Benefit of NOL carryforward ( 428,662 ) ( 130,834 ) Foreign tax differential 477,375 338,435 Impact of state tax rate change ( 3,177 ) 7,622 Global intangible low tax inclusion 135,721 - Foreign valuation allowance 45,278 ( 663,025 ) Impact of foreign permanent items other non deductible items 142,303 311,172 PPP loan forgiveness income - ( 1,334,901 ) Investment in subsidiary ( 5,694,916 ) - Tax credits and other permanent differences ( 76,654 ) - Foreign currency exchange (gain)/loss in local jurisdiction ( 47,951 ) 51,179 Foreign inflation adjustment ( 78,625 ) ( 107,608 ) Stock-based compensation 9,701 ( 95,963 ) Provision for income taxes $ 2,991,541 $ 4,980,003
Deferred Tax Assets And Liabilities	2023 2022 Deferred Tax Assets Federal, foreign & state NOL carryforwards $ 464,828 $ 822,140 Research and other credits 78,100 78,100 Other intangibles - US 443,460 527,469 Property, plant & equipment - 113,338 Reserves and accruals 1,428,485 1,222,395 Stock-based compensation 452,858 426,655 Capital loss carryforward 5,833,375 - Inventory 3,153,198 2,703,370 Interest expense carryforward 1,009,274 - Lease liabilities 2,079,443 2,909,748 Allowance for doubtful accounts 25,360 25,490 Other intangibles - foreign - 11,536 Investment in subsidiary 1,349,152 - Other 34,065 66,231 Federal benefit of state taxes - 16,800 Total gross deferred tax assets 16,351,598 8,923,272 Less: valuation allowance 7,703,517 1,703,141 Net deferred tax assets $ 8,648,081 $ 7,220,131 Deferred Tax Liabilities Property, machinery & equipment $ ( 3,641,468 ) $ ( 3,488,320 ) Prepaids ( 329,062 ) ( 459,588 ) Operating Lease right-of-use assets ( 1,956,894 ) ( 2,779,092 ) Federal benefit of state taxes ( 79,755 ) - Total deferred tax liabilities $ ( 6,007,179 ) $ ( 6,727,000 ) Deferred tax asset $ 2,640,902 $ 856,863 Deferred tax liability - ( 363,732 ) Net deferred tax asset $ 2,640,902 $ 493,131

Leases (Tables)

Leases (Tables)	12 Months Ended
	Apr. 30, 2023
Leases [Abstract]
Lease Assets And Liabilities Related To Balance Sheet Classification	April 30, April 30, Classification 2023 2022 Operating Leases: Right-of-use Assets Right-of-use assets $ 7,225,423 $ 10,946,764 Operating lease current liabilities Current portion of operating lease obligations 2,908,213 3,508,864 Operating lease noncurrent liabilities Operating lease obligations, less current portion 4,723,867 7,903,898 Finance Leases: Right-of-use Assets Property, machinery and equipment 5,294,097 5,561,243 Finance lease current liabilities Current portion of finance lease obligations 1,523,259 1,410,675 Finance lease noncurrent liabilities Finance lease obligations, less current portion 2,596,178 2,805,135
Components Of Lease Expense	April 30, April 30, Classification 2023 2022 Operating Leases: Operating lease cost Cost of products sold 2,544,415 2,403,465 Variable lease cost Cost of products sold 223,431 216,042 Short term lease cost Cost of products sold 9,000 7,200 Finance Leases: Amortization of right-of-use assets Cost of products sold 2,369,642 2,275,169 Interest expense Interest expense, net 414,863 293,334 Total 5,561,351 5,195,210
Weighted Average Lease Term And Discount Rate	April 30, April 30, 2023 2022 Operating Leases: Weighted average remaining lease term (months) 36.3 45.9 Weighted average discount rate 3.3 % 3.2 % Finance Leases: Weighted average remaining lease term (months) 31.79 36.21 Weighted average discount rate 9.8 % 9.5 %
Future Payments Due Under Operating And Finance Leases	Operating Leases Finance Leases For the fiscal years ending April 30: 2024 2,974,745 1,856,501 2025 2,450,683 1,674,988 2026 1,921,052 1,007,719 2027 343,006 177,772 2028 74,382 - Thereafter 63,717 - Total undiscounted lease payments 7,827,585 4,716,980 Present value discount, less interest 195,505 597,543 Lease liability $ 7,632,080 $ 4,119,437
Supplemental Cash Flow Information Related To Leases	April 30, April 30, Other Information 2023 2022 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from finance leases 414,863 293,334 Operating cash flows from operating leases 316,434 382,044 Financing cash flows from finance leases 1,695,829 1,855,822 Supplemental non-cash information on lease labilities arising from obtaining right-of-use assets: Right-of-use assets obtained in exchange for new finance lease liabilities 1,599,456 3,435,498 Right-of-use assets obtained in exchange for operating lease liabilities 3,721,341 2,716,298

Stock Compensation And Equity_2

Stock Compensation And Equity Transactions (Tables)	12 Months Ended
	Apr. 30, 2023
Summarized Option Activity	Number of Number of securities to be Weighted- options issued upon average exercisable exercise of exercise at end outstanding options price of year Outstanding at April 30, 2021 513,232 5.13 513,232 Options granted during 2022 464,500 6.26 Options exercised during 2022 ( 185,688 ) 5.02 Outstanding at April 30, 2022 792,044 5.79 549,669 Options cancelled during 2023 ( 11,650 ) 3.60 Options forfeited during 2023 ( 138,750 ) 6.66 Outstanding at April 30, 2023 641,644 $ 5.70 552,894
Stock Options Outstanding, Exercisable, And Non-vested	Options outstanding and exercisable Number Weighted-average Weighted- outstanding at remaining average April 30, 2023 contract life exercise price Range of exercise prices $ 3.20 - 6.66 552,894 5.72 years $ 5.54 552,894 $ 5.54
2019 Option Plan [Member]
Black-Scholes Option Pricing Model	2019 Option Plan Fiscal 2022 Awards Expected volatility 57.0 % Risk-free interest rate 0.93 % Expected life of options (in years) 5.25 Grant date fair value $ 4.83
2021 Option Plan [Member]
Black-Scholes Option Pricing Model	2021 Option Plan Fiscal 2022 Awards Expected volatility 67.0 % Risk-free interest rate 2.93 % Expected life of options (in years) 6.00 Grant date fair value $ 6.66

Discontinued Operations (Tables

Discontinued Operations (Tables)	12 Months Ended
	Apr. 30, 2023
Discontinued Operations [Abstract]
Discontinued Operations	Fiscal Year Ended April 30, 2023 2022 Net Sales $ 1,598,929 $ 549,929 Cost of products sold 1,732,352 509,327 Gross (loss) profit ( 133,423 ) 40,602 Selling and administrative expenses 9,656,999 2,920,277 Impairment of notes receivable and investment - 6,300,235 Impairment of goodwill and other long-lived assets 23,096,771 - Operating loss ( 32,887,193 ) ( 9,179,910 ) Loss on sale of a business ( 3,742,709 ) - Interest expense - 154 Loss before income taxes from discontinued operations ( 36,629,902 ) ( 9,180,064 ) Income tax benefit 1,860,093 678,313 Loss from discontinued operations $ ( 34,769,809 ) $ ( 8,501,751 ) NOTE P – DISCONTINUED OPERATIONS – Continued As noted above, the Company completed the sale of Wagz, effective as of April 1, 2023. The following amounts related to Wagz were classified as assets and liabilities of discontinued operations in the Consolidated Balance Sheet as of April 30, 2022: April 30, 2022 Cash and cash equivalents $ 556,054 Accounts receivable 81,508 Inventories, net 300,251 Prepaid expenses and other assets 62,068 Total current assets 999,881 Property, machinery and equipment, net 195,109 Intangible assets, net 10,759,315 Goodwill 13,320,534 Other assets 6,000 Total other long-term assets 24,280,958 TOTAL ASSETS $ 25,280,839 Trade accounts payable $ 85,780 Accrued expenses 419,820 Accrued wages 102,733 Total current liabilities 608,333 Deferred income taxes 215,000 Total long-term liabilities 215,000 TOTAL LIABILITIES $ 823,333

Selected Quarterly Financial _2

Selected Quarterly Financial Data From Continuing Operations (Tables)	12 Months Ended
	Apr. 30, 2023
Selected Quarterly Financial Data From Continuing Operations [Abstract]
Summary Of Quarterly Financial Data	First Second Third Fourth 2023 Quarter Quarter Quarter Quarter Net sales $ 105,189,979 $ 108,221,068 $ 92,736,725 $ 108,288,074 Gross profit 11,577,220 13,306,079 11,160,904 15,409,394 Income before income 4,129,636 4,858,965 2,892,683 5,304,681 taxes (1) Net income from continuing operations 3,600,236 3,602,998 2,949,459 4,041,731 Earnings per share from continuing operations $ 0.59 $ 0.59 $ 0.49 $ 0.67 Basic Earnings per share $ 0.58 $ 0.59 $ 0.49 $ 0.67 Diluted Weighted average shares- Basic 6,058,908 6,071,288 6,071,288 6,077,490 Weighted average shares- Diluted 6,191,395 6,145,223 6,071,288 6,077,490 The Company records inventory reserves for valuation and shrinkage throughout the year based on historical data. In the fourth quarter of fiscal year 2023 physical inventory results were completed resulting in an increase in income before taxes of approximately $ 650,000 net of a provision for inventory reserves of approximately $ 1,900,000 . NOTE Q - SELECTED QUARTERLY FINANCIAL DATA FROM CONTINUING OPERATIONS (UNAUDITED) - Continued On April 1, 2023, SigmaTron completed the sale of its Wagz, Inc. business. The results of the Wagz, Inc. business have been reported as discontinued operations in the Consolidated Statements of Operations through the date of sale. These changes have been applied to all periods presented. See Note P — Discontinued Operations, for additional information. The following is a summary of unaudited quarterly financial data for fiscal year 2022: First Second Third Fourth 2022 Quarter Quarter Quarter Quarter Net sales $ 85,739,434 $ 100,216,614 $ 93,478,557 $ 98,881,890 Gross profit 9,582,478 11,777,586 12,409,967 10,621,238 Income (loss) before income 9,553,661 4,663,717 ( 1,216,112 ) 10,344,656 taxes (1) (2) Net income (loss) from continuing operations 8,796,716 3,150,205 ( 1,960,520 ) 8,379,518 Earnings (loss) per share from continuing operations $ 2.06 $ 0.72 $ ( 0.41 ) $ 1.39 Basic Earnings (loss) per share $ 2.02 $ 0.69 $ ( 0.41 ) $ 1.34 Diluted Weighted average shares- Basic 4,275,410 4,313,623 4,729,619 6,021,803 Weighted average shares- Diluted 4,353,912 4,553,899 4,729,619 6,246,580 1) The Company was notified of the forgiveness of the PPP Loan by the SBA on July 9, 2021 and all its principal and accrued interest were forgiven. The accounting for the forgiveness in the amount of $ 6,282,973 is reflected in the Company’s Statement of Operations as a non-cash gain upon extinguishment of long-term debt in the first quarter of fiscal 2022. 2) The Company records inventory reserves for valuation and shrinkage throughout the year based on historical data. In the fourth quarter of fiscal year 2022 physical inventory results were completed resulting in a decrease in income before taxes of approximately $ 411,000 . The Company did no t record a provision for inventory reserves in the fourth quarter of fiscal 2022.

Description Of The Business (Na

Description Of The Business (Narrative) (Details) - USD ($)	Apr. 01, 2023	Apr. 30, 2023	Apr. 30, 2022	Dec. 31, 2021
Total assets located in foreign jurisdictions outside the United States		37%	35%
China [Member]
Total assets located in foreign jurisdictions outside the United States		10%	12%
Mexico [Member]
Total assets located in foreign jurisdictions outside the United States		25%	20%
Other Foreign Locations [Member]
Total assets located in foreign jurisdictions outside the United States		2%	3%
Wagz Business Disposed [Member]
Percentage of equity interest sold	81%
Wagz [Member]
Working capital term loan		$ 900,000
Investment in Wagz [Member]
Equity method investment, ownership percentage	19%			25.50%
Buyer [Member] | Investment in Wagz [Member]
Equity method investment, ownership percentage	81%

Summary Of Significant Accoun_4

Summary Of Significant Accounting Policies (Narrative) (Details) - USD ($)		3 Months Ended	12 Months Ended
	Dec. 31, 2021	Jan. 31, 2023	Apr. 30, 2023	Apr. 30, 2022	Dec. 31, 2021	Apr. 01, 2023
Summary Of Significant Accounting Policies [Line Items]
Impact of currency fluctuation, resulted net foreign currency losses			$ (892,642)	$ (412,218)
Proceeds from sale of trade receivables			$ 94,000,000	121,000,000
Accounts receivable average uncollectible period			5 years
Deferred financing fees			$ 1,608,558	401,040
Deferred finance cost accumulated amortization			457,992	99,477
Deferred income			$ 8,063,197	$ 11,394,820
Anti-dilutive common stock outstanding excluded from the calculation of diluted earnings per share			105,286	0
Impairment of goodwill			$ 13,320,534
Intangible asset impairment charge		$ 9,527,773
Contractual life of options			10 years
Revenues recognized from performance obligations satisfied or partially satisfied			$ 0
Amounts allocated to performance obligations remain unsatisfied or partially unsatisfied			0
Other receivables			5,349,328	$ 6,318,164
Asset Impairment Charges				6,300,235
Purchase of treasury stock related to acquisition				9,268,881	$ 9,268,881
Stock Issued During Period, Value, Acquisitions				25,245,177
Shares allocated to company and treated as treasury stock					897,278
Proceeds from issuance of new shares to raise additional capital				277,120
Reclassified insurance settlement from cash flows from operations to cash flows from investing activities			$ 54,921
Investment in Wagz [Member]
Summary Of Significant Accounting Policies [Line Items]
Fair value of non-cash consideration	$ 600,000				600,000
Secured promissory note	1,380,705				1,380,705
Convertible secured promissory note, outstanding	$ 12,000,000				$ 12,000,000
Notes converted to common stock	12,000,000				12,000,000
Equity method investment, ownership percentage	25.50%				25.50%	19%
Asset Impairment Charges				6,300,235
Minimum [Member]
Summary Of Significant Accounting Policies [Line Items]
Option exercise price as a percentage of market price of shares			100%
Patents [Member]
Summary Of Significant Accounting Policies [Line Items]
Estimated useful life			18 years
Trade Names [Member]
Summary Of Significant Accounting Policies [Line Items]
Estimated useful life			20 years
Customer Relationships [Member]
Summary Of Significant Accounting Policies [Line Items]
Estimated useful life			15 years
Wagz [Member]
Summary Of Significant Accounting Policies [Line Items]
Fair value of non-cash consideration	$ 6,299,765				$ 6,299,765
Business Acquisition, Percentage of Voting Interests Acquired	100%				100%
Asset Impairment Charges				$ 6,300,235
Stock Issued During Period, Shares, Acquisitions	1,546,592				2,443,870
Stock Issued During Period, Value, Acquisitions					$ 25,245,177
Shares allocated to company and treated as treasury stock					$ 897,278
Wagz Shareholders [Member] | Wagz [Member]
Summary Of Significant Accounting Policies [Line Items]
Stock Issued During Period, Shares, Acquisitions					1,546,592
Stock Issued During Period, Value, Acquisitions					$ 15,976,295

Summary Of Significant Accoun_5

Summary Of Significant Accounting Policies (Depreciation And Amortization Using Straight-Line Method Over Estimated Useful Life) (Details)	12 Months Ended
	Apr. 30, 2023
Buildings [Member]
Property Plant and Equipment Estimated Useful Lives [Line Items]
Property, Plant and Equipment, Useful Life	20 years
Machinery And Equipment [Member] | Minimum [Member]
Property Plant and Equipment Estimated Useful Lives [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Machinery And Equipment [Member] | Maximum [Member]
Property Plant and Equipment Estimated Useful Lives [Line Items]
Property, Plant and Equipment, Useful Life	12 years
Office Equipment And Software [Member] | Minimum [Member]
Property Plant and Equipment Estimated Useful Lives [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Office Equipment And Software [Member] | Maximum [Member]
Property Plant and Equipment Estimated Useful Lives [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Tools And Dies [Member]
Property Plant and Equipment Estimated Useful Lives [Line Items]
Property, Plant and Equipment, Useful Life	12 months
Leasehold Improvements [Member]
Property Plant and Equipment Estimated Useful Lives [Line Items]
Property, Plant and Equipment, Term of lease	lesser of lease term or useful life

Summary Of Significant Accoun_6

Summary Of Significant Accounting Policies (Computation Of Basic And Diluted Earnings Per Share) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2023	Apr. 30, 2022
Significant Accounting Policies [Abstract]
Net income from continuing operations	$ 4,041,731	$ 2,949,459	$ 3,602,998	$ 3,600,236	$ 8,379,518	$ (1,960,520)	$ 3,150,205	$ 8,796,716	$ 14,194,424	$ 18,365,919
Net loss from discontinued operations									(34,769,809)	(8,501,751)
Total net (loss) income									$ (20,575,385)	$ 9,864,168
Weighted-average shares - Basic	6,077,490	6,071,288	6,071,288	6,058,908	6,021,803	4,729,619	4,313,623	4,275,410	6,069,680	4,825,360
Weighted-average shares, Effect of dilutive stock options										303,874
Diluted	6,077,490	6,071,288	6,145,223	6,191,395	6,246,580	4,729,619	4,553,899	4,353,912	6,069,680	5,129,234
Basic earnings per share from continuing operations									$ 2.34	$ 3.81
Basic loss per share from discontinued operations									(5.73)	(1.77)
Basic total (loss) earnings per share	$ 0.67	$ 0.49	$ 0.59	$ 0.59	$ 1.39	$ (0.41)	$ 0.72	$ 2.06	(3.39)	2.04
Diluted earnings per share from continuing operations									2.34	3.58
Diluted loss per share from discontinued operations									(5.73)	(1.66)
Diluted total (loss) earnings per share	$ 0.67	$ 0.49	$ 0.59	$ 0.58	$ 1.34	$ (0.41)	$ 0.69	$ 2.02	$ (3.39)	$ 1.92

Significant Accounting Policies

Significant Accounting Policies (Revenue Disaggregated By Principal End-User Markets) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2023	Apr. 30, 2022
Disaggregation of Revenue [Line Items]
Total Net Trade Sales	$ 108,288,074	$ 92,736,725	$ 108,221,068	$ 105,189,979	$ 98,881,890	$ 93,478,557	$ 100,216,614	$ 85,739,434	$ 414,435,845	$ 378,316,495
Industrial Electronics [Member]
Disaggregation of Revenue [Line Items]
Total Net Trade Sales									278,844,264	209,405,083
Consumer Electronics [Member]
Disaggregation of Revenue [Line Items]
Total Net Trade Sales									109,043,652	145,972,308
Medical / Life Sciences [Member]
Disaggregation of Revenue [Line Items]
Total Net Trade Sales									$ 26,547,929	$ 22,939,104

Allowance For Doubtful Accoun_3

Allowance For Doubtful Accounts (Changes In Company's Allowance For Doubtful Accounts) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Allowance For Doubtful Accounts [Abstract]
Allowance for Doubtful Accounts, Beginning Balance	$ 100,000	$ 100,000
Bad debt expense
Bad debt recovery
Write-offs
Allowance for Doubtful Accounts, Ending Balance	$ 100,000	$ 100,000

Inventories, Net (Components Of

Inventories, Net (Components Of Inventory) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2021
Inventories [Abstract]
Finished products	$ 22,093,018	$ 21,875,390
Work-in-process	5,415,917	5,907,766
Raw materials	142,612,325	140,118,156
Total inventory, gross	170,121,260	167,901,312
Less obsolescence reserve	4,566,061	3,236,347	$ 2,414,310
Total inventory, net	$ 165,555,199	$ 164,664,965

Inventories (Changes In Invento

Inventories (Changes In Inventory Obsolescence Reserve) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Inventories [Abstract]
Beginning balance	$ 3,236,347	$ 2,414,310
Provision for obsolescence	488,000	1,711,599
Provision for Wagz inventory	1,441,063
Write-offs	(599,349)	(889,562)
Ending balance	$ 4,566,061	$ 3,236,347

Property, Machinery and Equip_3

Property, Machinery and Equipment, Net (Narrative) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Property, Machinery And Equipment, Net [Abstract]
Depreciation and amortization expense	$ 5,817,659	$ 5,720,157

Property, Machinery and Equip_4

Property, Machinery and Equipment, Net (Schedule Of Property, Machinery And Equipment) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Property, Machinery and Equipment [Line Items]
Property, machinery and equipment, gross	$ 128,835,036	$ 123,603,503
Less accumulated depreciation and amortization, including accumulated amortization of assets under finance leases of $1,006,128 and $1,081,476 at April 30, 2023 and 2022, respectively	93,046,679	87,825,397
Property, machinery and equipment, net	35,788,357	35,778,106
Accumulated amortization of assets under finance leases	1,006,128	1,081,476
Land And Buildings [Member]
Property, Machinery and Equipment [Line Items]
Property, machinery and equipment, gross	18,826,246	18,653,248
Machinery And Equipment [Member]
Property, Machinery and Equipment [Line Items]
Property, machinery and equipment, gross	85,895,593	81,551,714
Office Equipment And Software [Member]
Property, Machinery and Equipment [Line Items]
Property, machinery and equipment, gross	14,675,432	13,738,965
Leasehold Improvements [Member]
Property, Machinery and Equipment [Line Items]
Property, machinery and equipment, gross	3,137,540	3,016,857
Equipment Under Finance Leases [Member]
Property, Machinery and Equipment [Line Items]
Property, machinery and equipment, gross	$ 6,300,225	$ 6,642,719

Acquisition (Narrative) (Detail

Acquisition (Narrative) (Details) - USD ($)			12 Months Ended
	Apr. 01, 2023	Dec. 31, 2021	Apr. 30, 2022	Dec. 31, 2021
Impairment charge			$ 6,300,235
Stock Issued During Period, Value, Acquisitions			25,245,177
Shares allocated to company and treated as treasury stock				$ 897,278
Purchase of treasury stock related to acquisition			9,268,881	$ 9,268,881
Investment in Wagz [Member]
Equity method investment, ownership percentage	19%	25.50%		25.50%
Fair value of the common stock		$ 600,000		$ 600,000
Wagz common stock remeasured to fair value			6,299,765
Convertible Debt, Current		12,000,000		12,000,000
Secured promissory note		$ 1,380,705		$ 1,380,705
Notes converted to common stock		12,000,000		12,000,000
Impairment charge			6,300,235
Wagz [Member]
Business Acquisition, Percentage of Voting Interests Acquired		100%		100%
Fair value of the common stock		$ 6,299,765		$ 6,299,765
Impairment charge			$ 6,300,235
Stock Issued During Period, Value, Acquisitions				$ 25,245,177
Stock Issued During Period, Shares, Acquisitions		1,546,592		2,443,870
Shares allocated to company and treated as treasury stock				$ 897,278
Goodwill		$ 13,320,534		13,320,534
Wagz [Member] | Trade Names [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets		1,230,000		1,230,000
Wagz [Member] | Patents [Member]
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Finite-Lived Intangibles		$ 9,730,000		9,730,000
Wagz Shareholders [Member] | Wagz [Member]
Stock Issued During Period, Value, Acquisitions				$ 15,976,295
Stock Issued During Period, Shares, Acquisitions				1,546,592
Buyer [Member] | Investment in Wagz [Member]
Equity method investment, ownership percentage	81%
Wagz Business Disposed [Member]
Percentage of equity interest sold	81%

Acquisition (Consideration For

Acquisition (Consideration For Acquisition) (Details) - Wagz [Member]		12 Months Ended
	Dec. 31, 2021 USD ($) shares	Dec. 31, 2021 USD ($) shares
Business Acquisition [Line Items]
Issuance of 1,546,592 common stock of SigmaTron	$ 15,976,295
Fair value of consideration transferred	15,976,295
Secured Promissory Notes	1,380,173
Fair value of SigmaTron's equity interest in Wagz held prior to the business combination	6,299,765
Consideration	$ 23,656,233	$ 23,656,233
Common stock of SigmaTron | shares	1,546,592	2,443,870
Wagz Shareholders [Member]
Business Acquisition [Line Items]
Common stock of SigmaTron | shares		1,546,592

Acquisition (Preliminary Alloca

Acquisition (Preliminary Allocation Of Purchase Consideration) (Details) - Wagz [Member]	Dec. 31, 2021 USD ($)
Business Acquisition [Line Items]
Cash	$ 508,274
Working capital	224,046
Property, plant and equipment	201,839
Acquired intangible assets	10,960,000
Right-of-use operating lease assets	647,076
Other assets	6,000
Operating lease obligations	(647,077)
Deferred tax liability	(215,000)
Other liabilities	(1,349,459)
Goodwill	13,320,534
Fair value of purchase consideration	$ 23,656,233

Acquisition (Intangible Assets

Acquisition (Intangible Assets Acquired) (Details) - Wagz [Member]	Dec. 31, 2021 USD ($)
Business Acquisition [Line Items]
Provisional Fair Value	$ 10,960,000
Trade Names [Member]
Business Acquisition [Line Items]
Provisional Fair Value	$ 1,230,000
Weighted Average Amortization Period	20 years
Patents [Member]
Business Acquisition [Line Items]
Provisional Fair Value	$ 9,730,000
Weighted Average Amortization Period	18 years

Segment and Geographic Area I_3

Segment and Geographic Area Information (Schedule of Segment Reporting Information) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2023	Apr. 30, 2022
Segment Reporting Information [Line Items]
Net sales	$ 108,288,074	$ 92,736,725	$ 108,221,068	$ 105,189,979	$ 98,881,890	$ 93,478,557	$ 100,216,614	$ 85,739,434	$ 414,435,845	$ 378,316,495
Operating income (loss)									24,957,646	18,409,475
Gain on extinguishment of long-term debt										6,282,973
Other income									632,223	153,614
Interest expense, net									(8,403,904)	(1,500,140)
Income before income taxes	5,304,681	$ 2,892,683	$ 4,858,965	$ 4,129,636	10,344,656	$ (1,216,112)	$ 4,663,717	$ 9,553,661	17,185,965	23,345,922
Depreciation and amortization expense									5,817,659	5,720,157
Amortization of intangible assets									339,133	346,586
Identifiable assets	268,627,199				293,631,277				268,627,199	293,631,277
Continuing and discontinued operations [Member]
Segment Reporting Information [Line Items]
Net sales									416,034,774	378,866,424
Operating income (loss)									(7,929,547)	9,229,411
Gain on extinguishment of long-term debt										6,282,973
Other income									632,223	153,614
Interest expense, net									(8,403,904)	(1,500,140)
Income before income taxes									(15,701,228)	14,165,858
Purchases of machinery and equipment									4,468,588	4,749,532
Depreciation and amortization expense									5,863,536	5,736,318
Identifiable assets	268,627,199				293,631,277				268,627,199	293,631,277
Operating Segments [Member] | EMS Segment [Member] | Continuing Operations [Member]
Segment Reporting Information [Line Items]
Net sales									414,435,845	378,316,495
Operating income (loss)									24,957,646	18,409,475
Purchases of machinery and equipment									4,334,169	4,740,100
Depreciation and amortization expense									5,817,659	5,720,157
Identifiable assets	268,627,199				268,350,438				268,627,199	268,350,438
Operating Segments [Member] | Pet Tech Segment [Member] | Discontinued Operations [Member]
Segment Reporting Information [Line Items]
Net sales									1,598,929	549,929
Operating income (loss)									(32,887,193)	(9,180,064)
Purchases of machinery and equipment									134,419	9,432
Depreciation and amortization expense									$ 45,877	16,161
Identifiable assets					$ 25,280,839					25,280,839
Intersegment Eliminations [Member]
Segment Reporting Information [Line Items]
Net sales	$ 938,370									$ 213,298

Segment and Geographic Area I_4

Segment and Geographic Area Information (Schedule of Net Sales and Tangible Long-lived Assets by Geographical Areas) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2023	Apr. 30, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales	$ 108,288,074	$ 92,736,725	$ 108,221,068	$ 105,189,979	$ 98,881,890	$ 93,478,557	$ 100,216,614	$ 85,739,434	$ 414,435,845	$ 378,316,495
Total tangible long-lived assets, net	43,013,780				46,724,870				43,013,780	46,724,870
U.S. [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total tangible long-lived assets, net	20,371,298				21,538,417				20,371,298	21,538,417
China [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total tangible long-lived assets, net	4,212,780				5,060,021				4,212,780	5,060,021
Mexico [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total tangible long-lived assets, net	17,574,899				18,839,855				17,574,899	18,839,855
Other [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Total tangible long-lived assets, net	$ 854,803				$ 1,286,577				854,803	1,286,577
Operating Segments [Member] | U.S. [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales									117,389,877	89,119,720
Operating Segments [Member] | China [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales									48,584,165	46,347,260
Operating Segments [Member] | Vietnam [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales									11,523,284	13,981,553
Operating Segments [Member] | Mexico [Member]
Revenues from External Customers and Long-Lived Assets [Line Items]
Net sales									$ 236,938,519	$ 228,867,962

Intangible Assets (Narrative) (

Intangible Assets (Narrative) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Intangible Assets [Abstract]
Amortization expense	$ 339,133	$ 346,586
Fully amortized year	2028
Goodwill, Impairment Loss	$ 13,320,534

Intangible Assets (Summary Of I

Intangible Assets (Summary Of Intangible Assets Subject To Amortization) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 15,650,000	$ 4,690,000
Accumulated Amortization	4,033,663	3,039,837
Impairment Amount	9,527,773
Write off	777,534
Net Intangible Asset Balance	1,311,030	1,650,163
Spitfire [Member] | Non-Contractual Customer Relationship [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	4,690,000	4,690,000
Accumulated Amortization	3,378,970	3,039,837
Net Intangible Asset Balance	1,311,030	1,650,163
Wagz [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount, Discontinued Operations		10,960,000
Accumulated Amortization, Discontinued Operations		200,685
Net Intangible Asset Balance, Discontinued Operations		10,759,315
Wagz [Member] | Trade Names [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,230,000
Accumulated Amortization	68,380
Impairment Amount	813,960
Write off	347,660
Gross Carrying Amount, Discontinued Operations		1,230,000
Accumulated Amortization, Discontinued Operations		20,500
Net Intangible Asset Balance, Discontinued Operations		1,209,500
Wagz [Member] | Patents [Member]
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Amount	9,730,000
Accumulated Amortization	586,313
Impairment Amount	8,713,813
Write off	$ 429,874
Gross Carrying Amount, Discontinued Operations		9,730,000
Accumulated Amortization, Discontinued Operations		180,185
Net Intangible Asset Balance, Discontinued Operations		$ 9,549,815

Intangible Assets (Estimated Ag

Intangible Assets (Estimated Aggregate Amortization Expense) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Intangible Assets [Abstract]
For the fiscal years ending April 30, 2024	$ 331,842
For the fiscal years ending April 30, 2025	324,702
For the fiscal years ending April 30, 2026	317,728
For the fiscal years ending April 30, 2027	310,900
For the fiscal years ending April 30, 2028	25,858
Net Intangible Asset Balance	$ 1,311,030	$ 1,650,163

Long-Term Debt (Narrative) (Det

Long-Term Debt (Narrative) (Details)

3 Months Ended

12 Months Ended

Apr. 01, 2023

Feb. 17, 2023

Jul. 18, 2022 USD ($)

Apr. 25, 2022 USD ($)

Jan. 26, 2022

Jan. 17, 2022

Jan. 29, 2021 USD ($)

Mar. 03, 2020 USD ($)

Oct. 31, 2024 USD ($)

Jul. 31, 2024

Apr. 30, 2024

Jan. 31, 2024

Oct. 31, 2023

Apr. 30, 2023 USD ($)

Jan. 31, 2023

Oct. 31, 2022 USD ($)

Apr. 30, 2023 USD ($)

Apr. 30, 2022 USD ($)

Jul. 31, 2026

Apr. 30, 2020 USD ($)

Mar. 15, 2019 CNY (¥)

Debt Instrument [Line Items]

Deferred financing costs

$ 1,608,558

$ 1,608,558

$ 401,040

Other Liabilities Noncurrent

100,350

$ 100,350

$ 1,051,587

Wagz Business Disposed [Member]

Debt Instrument [Line Items]

Percentage of equity interest sold

81%

Waivers Agreement [Member]

Debt Instrument [Line Items]

Applicable Margin Rate Fixed

2%

Forecast [Member]

Debt Instrument [Line Items]

Total Debt to EBITDA Ratio

4

4.25

4.50

4.50

4.50

Finance Lease And Sales Leaseback Agreements [Member]

Debt Instrument [Line Items]

Maturity date

Apr. 01, 2027

TCW Term Loan [Member]

Debt Instrument [Line Items]

Amendment fee

395,000

$ 395,000

Debt instrument default rate fee

$ 188,301

TCW Term Loan [Member] | Waivers Agreement [Member]

Debt Instrument [Line Items]

Applicable Margin Rate Increase Per Annum

1%

TCW Term Loan [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Loan

$ 40,000,000

Outstanding balance under the credit facility

43,867,135

$ 43,867,135

Unamortized deferred financing costs

1,036,367

1,036,367

Deferred financing costs

$ 1,233,894

$ 1,233,894

Maturity date

Jul. 18, 2027

Debt Instrument, Periodic Payment

$ 250,000

Percentage of mandatory annual repayments

50%

Fixed charge coverage ratio

1.10

TCW Term Loan [Member] | Notes Payable - Secured Lenders [Member] | Forecast [Member]

Debt Instrument [Line Items]

Debt Instrument, Periodic Payment

$ 500,000

TCW Term Loan [Member] | SOFR Rate [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Variable interest rate

7.50%

FILO Term Loan [Member]

Debt Instrument [Line Items]

Credit facility

$ 5,000,000

Variable interest rate

4%

Effective interest rate

4.41%

Outstanding balance under the credit facility

$ 5,000,000

Term

120 days

U.S. Bank [Member] | Paycheck Protection Program [Member]

Debt Instrument [Line Items]

Loan

$ 6,282,973

JPMorgan Chase Bank [Member]

Debt Instrument [Line Items]

Amendment fee

$ 70,000

$ 70,000

Applicable Margin Rate Fixed

3%

JPMorgan Chase Bank [Member] | FCCR trigger period [Member]

Debt Instrument [Line Items]

Percentage of the revolving commitment

10%

Fixed charge coverage ratio

1.10

1.10

JPMorgan Chase Bank [Member] | Cash dominion period [Member]

Debt Instrument [Line Items]

Percentage of the revolving commitment

10%

JPMorgan Chase Bank [Member] | Waivers Agreement [Member]

Debt Instrument [Line Items]

Unused availability under the credit facility

2,500,000

$ 2,500,000

JPMorgan Chase Bank [Member] | JPM Waiver Applicable Rate 2 percent [Member]

Debt Instrument [Line Items]

Applicable Margin Rate Variable

2%

JPMorgan Chase Bank [Member] | JPM Waiver, Applicable Rate 2.5 percent [Member]

Debt Instrument [Line Items]

Applicable Margin Rate Variable

2.50%

JPMorgan Chase Bank [Member] | JPM Waiver, Applicable Rate 3 percent [Member]

Debt Instrument [Line Items]

Unused availability under the credit facility

10,000,000

$ 10,000,000

Applicable Margin Rate Variable

3%

JPMorgan Chase Bank [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Leverage ratio

5

Term Loan Borrowing Base Coverage Ratio

5.50

JPMorgan Chase Bank [Member] | Notes Payable - Secured Lenders [Member] | Forecast [Member]

Debt Instrument [Line Items]

Leverage ratio

3

Term Loan Borrowing Base Coverage Ratio

4

JPMorgan Chase Bank [Member] | Notes Payable - Buildings [Member] | Corporate Headquarters And Manufacturing Facility [Member]

Debt Instrument [Line Items]

Mortgage agreement, amount

$ 6,500,000

Mortgage agreement, final payment

4,368,444

$ 4,368,444

Mortgage agreement, maturity date

Jan. 29, 2026

Mortgage agreement, outstanding amount

0

$ 0

5,994,445

JPMorgan Chase Bank [Member] | TCW Term Loan [Member]

Debt Instrument [Line Items]

Total Debt to EBITDA Ratio

5

JPMorgan Chase Bank [Member] | Amended Facility [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Outstanding balance under the credit facility

51,134,699

51,134,699

51,392,158

Unused availability under the credit facility

11,539,183

11,539,183

5,691,855

Deferred financing costs

332,139

332,139

128,733

Unamortized amount

572,191

572,191

393,503

The Bank And Trust SSB [Member] | Notes Payable - Buildings [Member] | Warehousing And Distribution Center [Member]

Debt Instrument [Line Items]

Variable interest rate

1%

Mortgage agreement, amount

$ 556,000

Mortgage agreement, monthly principal payment

$ 6,103

Mortgage agreement, interest rate

5.75%

Mortgage agreement, payable period

120 days

Mortgage agreement, outstanding amount

$ 417,143

$ 417,143

464,895

Engencap Fin S.A. DE C.V. [Member] | Notes Payable - Equipment [Member]

Debt Instrument [Line Items]

Fixed interest rate

8%

8%

Maturity date

May 01, 2023

Debt Instrument, Periodic Payment

$ 9,310

Minimum [Member] | Finance Lease And Sales Leaseback Agreements [Member]

Debt Instrument [Line Items]

Fixed interest rate

7.09%

7.09%

Debt Instrument, Periodic Payment

$ 2,874

Minimum [Member] | TCW Term Loan [Member] | SOFR Rate [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Variable interest rate

1%

Minimum [Member] | JPMorgan Chase Bank [Member]

Debt Instrument [Line Items]

Unused availability under the credit facility

$ 20,000,000

$ 20,000,000

Minimum [Member] | JPMorgan Chase Bank [Member] | No event of default [Member]

Debt Instrument [Line Items]

Percentage of the revolving commitment

10%

Minimum [Member] | JPMorgan Chase Bank [Member] | JPM Waiver, Applicable Rate 2.5 percent [Member]

Debt Instrument [Line Items]

Unused availability under the credit facility

$ 10,000,000

$ 10,000,000

Minimum [Member] | FGI Equipment Finance LLC [Member] | Notes Payable - Equipment [Member]

Debt Instrument [Line Items]

Fixed interest rate

8.25%

8.25%

Maturity date

Mar. 01, 2025

Debt Instrument, Periodic Payment

$ 10,723

Maximum [Member]

Debt Instrument [Line Items]

Percentage of the revolving commitment

10%

Maximum [Member] | Finance Lease And Sales Leaseback Agreements [Member]

Debt Instrument [Line Items]

Fixed interest rate

12.73%

12.73%

Debt Instrument, Periodic Payment

$ 33,706

Maximum [Member] | JPMorgan Chase Bank [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Term Loan Borrowing Base Coverage Ratio

1.50

Maximum [Member] | JPMorgan Chase Bank [Member] | Amended Facility [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Credit facility

$ 70,000,000

Maximum [Member] | FGI Equipment Finance LLC [Member] | Notes Payable - Equipment [Member]

Debt Instrument [Line Items]

Fixed interest rate

9.25%

9.25%

Maturity date

Oct. 01, 2027

Debt Instrument, Periodic Payment

$ 69,439

Foreign Subsidiaries [Member] | Seniority Premiums [Member]

Debt Instrument [Line Items]

Other Liabilities Noncurrent

$ 100,350

100,350

1,051,587

Foreign Subsidiaries [Member] | Retirement Accounts [Member]

Debt Instrument [Line Items]

Other Liabilities Noncurrent

957,528

SigmaTron Electronic Technology Co [Member] | China Construction Bank [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Credit facility

1,444,252

1,444,252

Expiration date

Feb. 07, 2024

Jan. 06, 2022

Dec. 23, 2022

Fixed interest rate

3.35%

Outstanding balance under the credit facility

$ 0

$ 0

$ 438,219

SigmaTron Electronic Technology Co [Member] | Maximum [Member] | China Construction Bank [Member] | Notes Payable - Secured Lenders [Member]

Debt Instrument [Line Items]

Credit facility | ¥

¥ 10,000,000

Long-Term Debt (Schedule Of Deb

Long-Term Debt (Schedule Of Debt And Finance Lease Obligations) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Debt Instrument [Line Items]
Unamortized deferred financing costs	$ (1,608,558)	$ (401,040)
Total debt	93,300,700	67,090,969
Less current maturities	52,761,520	6,991,567
Long-term debt	40,539,180	60,099,402
Finance lease obligations	4,119,437	4,215,810
Less current maturities	1,523,259	1,410,675
Total finance lease obligations, less current portion	2,596,178	2,805,135
Notes Payable - Banks [Member]
Debt Instrument [Line Items]
Debt	90,968,000	56,830,377
Total debt	89,359,442
Notes Payable - Buildings [Member]
Debt Instrument [Line Items]
Debt	417,143	6,459,340
Total debt	417,143
Notes Payable - Equipment [Member]
Debt Instrument [Line Items]
Debt	3,524,115	$ 4,202,292
Total debt	$ 3,524,115

Long-Term Debt (Schedule Of D_2

Long-Term Debt (Schedule Of Debt To EBITDA Ratio) (Details) - Forecast [Member]	3 Months Ended
	Oct. 31, 2024	Jul. 31, 2024	Apr. 30, 2024	Jan. 31, 2024	Oct. 31, 2023
Debt Instrument [Line Items]
Total Debt to EBITDA Ratio	4	4.25	4.50	4.50	4.50
Prior To Amendment[Member]
Debt Instrument [Line Items]
Total Debt to EBITDA Ratio	3.75	3.75	4	4	4.25

Long-Term Debt (Aggregate Amoun

Long-Term Debt (Aggregate Amount Of Debt, Net Deferred Financing Fees) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
For the fiscal years ending April 30:
2024	$ 52,761,520
2025	2,731,815
2026	2,649,605
2027	2,102,425
2028	32,922,721
Thereafter	132,614
Total debt	93,300,700	$ 67,090,969
Notes Payable - Banks [Member]
For the fiscal years ending April 30:
2024	51,562,508
2025	1,501,272
2026	1,751,272
2027	1,751,272
2028	32,793,118
Thereafter
Total debt	89,359,442
Notes Payable - Buildings [Member]
For the fiscal years ending April 30:
2024	50,571
2025	53,557
2026	56,719
2027	60,068
2028	63,614
Thereafter	132,614
Total debt	417,143
Notes Payable - Equipment [Member]
For the fiscal years ending April 30:
2024	1,148,441
2025	1,176,986
2026	841,614
2027	291,085
2028	65,989
Thereafter
Total debt	3,524,115
Facility And TCW Term Loan [Member]
For the fiscal years ending April 30:
Total debt	$ 89,359,442
Maturity date	Jul. 18, 2027

Long-Term Debt (Future Minimum

Long-Term Debt (Future Minimum Obligations Under Finance Leases And Sale Leaseback) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Long-Term Debt [Abstract]
2024	$ 1,856,501
2025	1,674,988
2026	1,007,719
2027	177,772
2028
Total minimum lease payments	4,716,980
Less: Amounts representing interest	597,543
Present value of net minimum lease payments	$ 4,119,437	$ 4,215,810

Accrued Expenses And Wages (Sch

Accrued Expenses And Wages (Schedule Of Accrued Expenses) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Accrued Expenses And Wages [Abstract]
Interest	$ 505,423	$ 156,776
Commissions	193,480	141,008
Professional fees	268,526	475,761
Other - Purchases	359,647	852,862
Other	1,606,354	1,126,695
Accrued expenses, total	$ 2,933,430	$ 2,753,102

Accrued Expenses And Wages (S_2

Accrued Expenses And Wages (Schedule Of Accrued Wages) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Accrued Expenses And Wages [Abstract]
Domestic wages	$ 2,184,469	$ 2,597,312
Bonuses	2,282,927	3,624,794
Foreign wages	3,449,870	2,855,743
Accrued wages, total	$ 7,917,266	$ 9,077,849

Income Tax (Narrative) (Details

Income Tax (Narrative) (Details) - USD ($)	12 Months Ended	24 Months Ended
	Apr. 30, 2023	Apr. 30, 2023	Apr. 30, 2022
Income Tax [Line Items]
Deferred Tax Assets Valuation Allowance	$ 7,703,517	$ 7,703,517	$ 1,703,141
Unremitted earnings from foreign subsidiaries	11,822,000	11,822,000
Unrecognized tax benefits	0	0
Interest and penalties related to tax positions		0
Paycheck Protection Program [Member] | U.S. Bank [Member]
Income Tax [Line Items]
Debt Instrument, Face Amount	6,282,973	6,282,973
Foreign [Member]
Income Tax [Line Items]
Net operating loss carryforwards	$ 2,302,000	2,302,000
Net operating loss carryforwards begin to expire, year	2024
Tax Credit Carryforward, Valuation Allowance	$ 7,260,628	7,260,628
Vietnam [Member] | Foreign [Member]
Income Tax [Line Items]
Tax credit carryforwards	$ 442,889	$ 442,889

Income Tax (Income Before Incom

Income Tax (Income Before Income (Loss) Tax Expense (Benefit)) (Detail) - USD ($)	3 Months Ended								12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2023	Apr. 30, 2022
Income Tax [Abstract]
Domestic									$ 11,138,944	$ 19,155,489
Foreign									6,047,021	4,190,433
Income before income taxes	$ 5,304,681	$ 2,892,683	$ 4,858,965	$ 4,129,636	$ 10,344,656	$ (1,216,112)	$ 4,663,717	$ 9,553,661	$ 17,185,965	$ 23,345,922

Income Tax (Income Tax Expense)

Income Tax (Income Tax Expense) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Current
Federal	$ 3,219,203	$ 2,255,406
State	742,275	560,436
Foreign	1,392,834	1,010,149
Total Current	5,354,312	3,825,991
Deferred
Federal	(2,282,300)	1,315,037
State	(459,788)	326,217
Foreign	379,317	(487,242)
Total Deferred	(2,362,771)	1,154,012
Provision for income taxes	$ 2,991,541	$ 4,980,003

Income Tax (Reconciliation Of I

Income Tax (Reconciliation Of Income Taxes) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
U.S. Federal Provision:
At statutory rate	$ 3,609,047	$ 4,902,642
State taxes	(1,007,854)	521,668
Change in valuation allowance	5,909,955	1,179,616
Benefit of NOL carryforward	(428,662)	(130,834)
Foreign tax differential	477,375	338,435
Impact of state tax rate change	(3,177)	7,622
Global intangible low tax inlcusion	135,721
Foreign valuation allowance	45,278	(663,025)
Impact of foreign permanent items other non deductible items	(142,303)	(311,172)
PPP loan forgiveness income		(1,334,901)
Investment in subsidiary	(5,694,916)
Tax credits and other permanent differences	(76,654)
Foreign currency exchange (gain)/loss in local jurisdiction	(47,951)	51,179
Foreign inflation adjustment	(78,625)	(107,608)
Stock based compensation	9,701	(95,963)
Provision for income taxes	$ 2,991,541	$ 4,980,003

Income Tax (Deferred Tax Assets

Income Tax (Deferred Tax Assets And Liabilities) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Deferred Tax Assets
Federal, foreign & state NOL carryforwards	$ 464,828	$ 822,140
Research & Other Credits	78,100	78,100
Other intangibles - US	443,460	527,469
Property, plant & equipment		113,338
Reserves and accruals	1,428,485	1,222,395
Stock based compensation	452,858	426,655
Capital loss carryforward	5,833,375
Inventory	3,153,198	2,703,370
Interest expense carryforward	1,009,274
Lease liabilities	2,079,443	2,909,748
Allowance for doubtful accounts	25,360	25,490
Other intangibles - foreign		11,536
Investment in subsidiary	1,349,152
Other	34,065	66,231
Federal benefit of state taxes		16,800
Total gross deferred tax assets	16,351,598	8,923,272
Less: valuation allowance	7,703,517	1,703,141
Net deferred tax assets	8,648,081	7,220,131
Deferred Tax Liabilities
Property, machinery & equipment	(3,641,468)	(3,488,320)
Prepaids	(329,062)	(459,588)
Operating Lease right-of-use assets	(1,956,894)	(2,779,092)
Federal benefit of state taxes	(79,755)
Total deferred tax liabilities	(6,007,179)	(6,727,000)
Deferred tax asset	2,640,902	856,863
Deferred tax liability		(363,732)
Net deferred tax asset	$ 2,640,902	$ 493,131

401(k) Retirement Savings Plan

401(k) Retirement Savings Plan (Narrative) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Retirement Plans [Line Items]
Annual contribution to be matched by employer per participant	25%
Percentage of match to participant contributions	5%
Amount contributed towards retirement plans	$ 204,924	$ 199,054
Plan administration incurred total expenses	17,325	$ 20,280
Maximum [Member]
Retirement Plans [Line Items]
Annual contribution to be matched by employer per participant	$ 2,000

Major Customers and Concentra_2

Major Customers and Concentration of Credit Risk (Narrative) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	May 01, 2015
Maximum [Member]
Concentration Risk [Line Items]
Amount FDIC deposit insurance insures	$ 250,000
China [Member]
Concentration Risk [Line Items]
Cash	$ 404,741
Amount insured by deposit insurance program			$ 81,000
Major Customer One [Member] | Revenue Benchmark [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk from major customer, percentage	13.40%	21.80%
Major Customer One [Member] | Accounts Receivable [Member] | Customer Concentration Risk [Member]
Concentration Risk [Line Items]
Concentration risk from major customer, percentage	6.80%	4%

Leases (Narratives) (Details)

Leases (Narratives) (Details)	Apr. 30, 2023
Minimum [Member]
Leases [Line Items]
Operating leases, term	1 year
Maximum [Member]
Leases [Line Items]
Operating leases, term	5 years

Leases (Lease Assets And Liabil

Leases (Lease Assets And Liabilities Related To Balance Sheet Classification) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Operating Leases: Right-of-use Assets	$ 7,225,423	$ 10,946,764
Operating lease current liabilities	2,908,213	3,508,864
Operating lease noncurrent liabilities	$ 4,723,867	$ 7,903,898
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property Plant And Equipment Net	Property Plant And Equipment Net
Finance lease current liabilities	$ 1,523,259	$ 1,410,675
Finance lease noncurrent liabilities	$ 2,596,178	$ 2,805,135

Leases (Components Of Lease Exp

Leases (Components Of Lease Expense) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Operating lease cost	$ 2,544,415	$ 2,403,465
Variable lease cost	223,431	216,042
Short term lease cost	9,000	7,200
Amortization of right-of-use assets	2,369,642	2,275,169
Interest expense	414,863	293,334
Total	$ 5,561,351	$ 5,195,210

Leases (Weighted Average Lease

Leases (Weighted Average Lease Term And Discount Rate) (Details)	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Operating Leases: Weighted average remaining lease term (months)	36 months 9 days	45 months 27 days
Operating Leases: Weighted average discount rate	3.30%	3.20%
Finance Leases: Weighted average remaining lease term (months)	31 months 24 days	36 months 6 days
Finance Leases: Weighted average discount rate	9.80%	9.50%

Leases (Future Payments Due Und

Leases (Future Payments Due Under Operating And Finance Leases) (Details) - USD ($)	Apr. 30, 2023	Apr. 30, 2022
Operating Leases
For the fiscal year ending April 30: 2024	$ 2,974,745
For the fiscal year ending April 30: 2025	2,450,683
For the fiscal year ending April 30: 2026	1,921,052
For the fiscal year ending April 30: 2027	343,006
For the fiscal year ending April 30: 2028	74,382
Thereafter	63,717
Total undiscounted lease payments	7,827,585
Present value discount, less interest	195,505
Lease liability	7,632,080
Finance Leases
For the fiscal year ending April 30: 2024	1,856,501
For the fiscal year ending April 30: 2025	1,674,988
For the fiscal year ending April 30: 2026	1,007,719
For the fiscal year ending April 30: 2027	177,772
For the fiscal year ending April 30: 2028
Thereafter
Total undiscounted lease payments	4,716,980
Present value discount, less interest	597,543
Lease liability	$ 4,119,437	$ 4,215,810

Leases (Supplemental Cash Flow

Leases (Supplemental Cash Flow Information Related To Leases) (Details) - USD ($)	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022
Leases [Abstract]
Operating cash flows from finance leases	$ 414,863	$ 293,334
Operating cash flows from operating leases	316,434	382,044
Financing cash flows from finance leases	1,695,829	1,855,822
Right-of-use assets obtained in exchange for new finance lease liabilities	1,599,456	3,435,498
Right-of-use assets obtained in exchange for operating lease liabilities	$ 3,721,341	$ 2,716,298

Stock Compensation And Equity_3

Stock Compensation And Equity Transactions (Narrative) (Details)	1 Months Ended			3 Months Ended			12 Months Ended
	Sep. 30, 2022 shares	Jan. 31, 2022 shares	Jul. 31, 2021 shares	Apr. 30, 2023 USD ($) shares	Apr. 30, 2022 USD ($) shares	Jul. 31, 2021 shares	Apr. 30, 2023 USD ($) shares	Apr. 30, 2022 USD ($) shares
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Options granted								464,500
Recognized stock-based compensation | $							$ 184,343	$ 622,244
Aggregate intrinsic value of options outstanding | $				$ 0	$ 715,678		$ 0	715,678
Forfeited options							138,750
Non-vested stock options				88,750			88,750
Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Balance of unrecognized compensation expense | $				$ 0	$ 49,873		$ 0	49,873
2018 Non-Employee Director Restricted Stock Plan, fully vests on January 8, 2022 [Member] | Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Recognized stock-based compensation | $							$ 37,125
Restricted stock issued			7,500
Employees Plan [Member] | Option Plans [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period							6 months
Non Employee Director Plan [Member] | Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for future issuance				40,000			40,000
Vesting period							6 months
2018 Non-Employee Director Restricted Stock Plan [Member] | Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Restricted stock issued		15,000
2021 Non-Employee Director Restricted Stock Plan [Member] | Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Recognized stock-based compensation | $							$ 49,873	$ 81,675
Restricted stock issued	20,000
2021 Non-Employee Director Restricted Stock Plan, vested on March 29, 2023 [Member] | Restricted Stock [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Recognized stock-based compensation | $							98,199
Unrecognized compensation expense | $				$ 0			$ 0
2019 Option Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting period					2 years
2019 Option Plan [Member] | Option Plans [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of shares available for future issuance				187,900			187,900
Maximum term of options granted							10 years
Options granted						102,000
Recognized stock-based compensation | $							$ 245,770
Unrecognized compensation expense | $				$ 0			0
2021 Option Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Number of options eligible to purchase under the plan					400,000			400,000
Options granted					362,500
Recognized stock-based compensation | $							$ 184,343	$ 376,474
Forfeited options							138,750
Balance of unrecognized compensation expense | $				$ 368,685	$ 1,129,423		$ 368,685	$ 1,129,423
Vesting percentage for future							25
Number of shares authorized					400,000			400,000
2021 Option Plan [Member] | Fourth quarter of fiscal year 2022 [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Vesting percentage				25%	25%

Stock Compensation And Equity_4

Stock Compensation And Equity Transactions (Black-Scholes Option Pricing Model) (Details)	12 Months Ended
	Apr. 30, 2023 $ / shares
2019 Option Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility	57%
Risk-free interest rate	0.93%
Expected life of options (in years)	5 years 3 months
Grant date fair value	$ 4.83
2021 Option Plan [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Expected volatility	67%
Risk-free interest rate	2.93%
Expected life of options (in years)	6 years
Grant date fair value	$ 6.66

Stock Compensation And Equity_5

Stock Compensation And Equity Transactions (Summarized Option Activity) (Details) - $ / shares	12 Months Ended
	Apr. 30, 2023	Apr. 30, 2022	Apr. 30, 2021
Number of securities to be issued upon exercise of outstanding options
Outstanding, beginning balance	792,044	513,232
Options granted		464,500
Options exercised		(185,688)
Options cancelled	(11,650)
Options forfeited	(138,750)
Outstanding, ending balance	641,644	792,044
Weighted-average exercise price
Outstanding, Weighted-average exercise price, beginning balance	$ 5.79	$ 5.13
Options granted, Weighted-average exercise price		6.26
Options exercised, Weighted-average exercise price		5.02
Options cancelled Weighted-average exercise price	3.60
Options forfeited Weighted-average exercise price	6.66
Outstanding, Weighted-average exercise price, ending balance	$ 5.70	$ 5.79
Outstanding, Number of options exercisable at end of year	552,894	549,669	513,232

Stock Compensation And Equity_6

Stock Compensation And Equity Transactions (Stock Options Outstanding, Exercisable, And Non-vested) (Details)	12 Months Ended
	Apr. 30, 2023 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number outstanding, Options outstanding and exercisable | shares	552,894
Weighted-average exercise price, Options outstanding and exercisable	$ 5.54
$3.60 - 5.40 [Member]
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Range of exercise prices, lower	3.20
Range of exercise prices, upper	$ 6.66
Number outstanding, Options outstanding and exercisable | shares	552,894
Weighted-average remaining contract life, Options outstanding and exercisable	5 years 8 months 19 days
Weighted-average exercise price, Options outstanding and exercisable	$ 5.54

Discontinue Operations (Details

Discontinue Operations (Details) - USD ($)		3 Months Ended	12 Months Ended
	Apr. 01, 2023	Jan. 31, 2023	Apr. 30, 2023	Apr. 30, 2022
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Impairment of goodwill and other long-lived assets		$ 9,527,773
Loss before income taxes from discontinued operations			$ (36,629,902)	$ (9,180,064)
Income tax benefit from discontinued operations			1,860,093	678,313
Loss from discontinued operations			(34,769,809)	(8,501,751)
Disposal Group, Including Discontinued Operation, Assets [Abstract]
Cash and cash equivalents				556,054
Accounts Receivable				81,508
Inventories, net				300,251
Prepaid expenses and other assets				62,068
Total current assets				999,881
Property, machinery and equipment, net				195,109
Intangible assets, net				10,759,315
Goodwill				13,320,534
Other assets				6,000
Total other long-term assets				24,280,958
TOTAL ASSETS				25,280,839
Disposal Group, Including Discontinued Operation, Liabilities [Abstract]
Trade accounts payable				85,780
Accrued expenses				419,820
Accrued wages				102,733
Total current liabilities				608,333
Disposal Group, Including Discontinued Operation, Deferred Tax Liabilities				215,000
Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent				215,000
Disposal Group, Including Discontinued Operation, Liabilities				823,333
Pet Tech Segment (Wagz Business) [Member]
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Net sale			1,598,929	549,929
Cost of products sold			1,732,352	509,327
Gross (loss) profit			(133,423)	40,602
Selling and administrative expenses			9,656,999	2,920,277
Impairment of notes receivable and investment				6,300,235
Impairment of goodwill and other long-lived assets			23,096,771
Operating loss			(32,887,193)	(9,179,910)
Loss on sale of a business			(3,742,709)
Interest expense				154
Loss before income taxes from discontinued operations			(36,629,902)	(9,180,064)
Income tax benefit from discontinued operations			1,860,093	678,313
Loss from discontinued operations			$ (34,769,809)	$ (8,501,751)
Wagz Business Disposed [Member]
Disposal Group, Including Discontinued Operation, Income Statement Disclosures [Abstract]
Percentage of equity interest sold	81%

Selected Quarterly Financial _3

Selected Quarterly Financial Data From Continuing Operations (Summary Of Quarterly Financial Data) (Details) - USD ($)	3 Months Ended								12 Months Ended
	Apr. 30, 2023	Jan. 31, 2023	Oct. 31, 2022	Jul. 31, 2022	Apr. 30, 2022	Jan. 31, 2022	Oct. 31, 2021	Jul. 31, 2021	Apr. 30, 2023	Apr. 30, 2022
Selected Quarterly Financial Data From Continuing Operations [Abstract]
Net sales	$ 108,288,074	$ 92,736,725	$ 108,221,068	$ 105,189,979	$ 98,881,890	$ 93,478,557	$ 100,216,614	$ 85,739,434	$ 414,435,845	$ 378,316,495
Gross profit	15,409,394	11,160,904	13,306,079	11,577,220	10,621,238	12,409,967	11,777,586	9,582,478	51,453,597	44,391,269
Income (loss) before income taxes	5,304,681	2,892,683	4,858,965	4,129,636	10,344,656	(1,216,112)	4,663,717	9,553,661	17,185,965	23,345,922
Net income (loss) from continuing operations	$ 4,041,731	$ 2,949,459	$ 3,602,998	$ 3,600,236	$ 8,379,518	$ (1,960,520)	$ 3,150,205	$ 8,796,716	$ 14,194,424	$ 18,365,919
Earnings (loss) per share, Basic	$ 0.67	$ 0.49	$ 0.59	$ 0.59	$ 1.39	$ (0.41)	$ 0.72	$ 2.06	$ (3.39)	$ 2.04
Earnings (loss) per share, Diluted	$ 0.67	$ 0.49	$ 0.59	$ 0.58	$ 1.34	$ (0.41)	$ 0.69	$ 2.02	$ (3.39)	$ 1.92
Weighted-average shares - Basic	6,077,490	6,071,288	6,071,288	6,058,908	6,021,803	4,729,619	4,313,623	4,275,410	6,069,680	4,825,360
Weighted average shares- Diluted	6,077,490	6,071,288	6,145,223	6,191,395	6,246,580	4,729,619	4,553,899	4,353,912	6,069,680	5,129,234
Inventory adjustment	$ 650,000				$ (411,000)				$ 650,000	$ (411,000)
Provision for inventory reserves	$ 1,900,000									0
Gain on extinguishment of long-term debt										$ 6,282,973